# EPP & Feature Selection


## Content


# Events Per Parameter (EPP) & Feature Selection Reflection 


### Diagnostic Framework for Feature Utilisation in UK Biobank






## 1. Feature Selection: The One Thing We Control


In any prediction modelling workflow, especially in constrained large corpuses like biobanks, researchers face a fundamental asymmetry:





~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                  â”‚
â”‚  <strong> WHAT WE CANNOT CONTROL:  </strong>                                      â”‚
â”‚   â€¢ The outcome distribution in our data                         â”‚
â”‚   â€¢ The signal-to-noise ratio in the underlying biology          â”‚
â”‚   â€¢ The sample size available (often fixed by study design)      â”‚
â”‚   â€¢ Whether our model will generalise to new populations         â”‚
â”‚                                                                  â”‚
â”‚   <strong>WHAT WE CAN CONTROL:   </strong>                                        â”‚
â”‚   â€¢ Which features we select for our model                       â”‚
â”‚                                                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                  â”‚
â”‚  \textbf{ WHAT WE CANNOT CONTROL:  }                                      â”‚
â”‚   â€¢ The outcome distribution in our data                         â”‚
â”‚   â€¢ The signal-to-noise ratio in the underlying biology          â”‚
â”‚   â€¢ The sample size available (often fixed by study design)      â”‚
â”‚   â€¢ Whether our model will generalise to new populations         â”‚
â”‚                                                                  â”‚
â”‚   \textbf{WHAT WE CAN CONTROL:   }                                        â”‚
â”‚   â€¢ Which features we select for our model                       â”‚
â”‚                                                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
\end{Verbatim}
~~~




Feature selection is arguably the most consequential decision made by researchers. As Guyon and Elisseeff (2003) articulated in their foundational review, the objectives of variable selection are three-fold: improving prediction performance, providing faster and more cost-effective predictors, and providing a better understanding of the underlying process that generated the data.







This applies to all UK Biobank study types, not just machine learning.


- **Prediction models** select features (predictors) to forecast outcomes
- **GWAS** select covariates to adjust for confounding while testing genetic variants

    (Aschard et al., 2017; Dor et al., 2023)
    

- **Genetic risk scores** select which SNPs to include and weight
- **Epidemiological analyses** select confounders and effect modifiers to include in regression models





The principle of "garbage in, garbage out" that output quality is bounded by input quality, applies across all these contexts. No algorithm can extract signal from features that lack predictive information, nor can it correct for systematically poor feature choices across a research field (Canbek et al., 2022).







This raises the question: if feature selection is the primary controllable element across biobank research, how systematically is it being approached?







---


## 2. A Brief History of Feature Selection Methodology


### 2.1 Stepwise Regression (1960s)


Automated feature selection began with Efroymson (1960), who proposed stepwise regression as an efficient algorithm for selecting variables in multiple linear regression. The method iteratively adds or removes predictors based on their statistical significance (typically F-tests or t-tests).



Stepwise methods became standard practice throughout the 1960sâ€“1990s and were implemented in major statistical software (SAS, SPSS). However, substantial criticism has been accumulated.






- Standard errors are biased downward (if small underestimate true uncertainty)
- Coefficient estimates are biased upward (if big could exaggerate)
- The method is unstable, small data changes produce different selected variables
- It does not account for model uncertainty

Flom & Cassell, 2007 â€”â†’ paper not avaible 



### 2.2 The "10 Events Per Variable" Rule (1990s)


Alongside concerns about stepwise selection, researchers have asked how many variables a model can support before overfitting.



Simulation studies in the 1990s, notably Peduzzi et al. (1996), suggested that logistic regression models required approximately 10 "events per variable" (EPV) to produce stable coefficient estimates. This has been widely cited as a threshold for an adequate sample size.







Critical limitation: The rule used "variable" ambiguously. Does a 4-level categorical variable count as one variable or three? The lack of precision leads to inconsistent applications.







### 2.3 Events Per Parameter: The Modern Refinement (2010sâ€“present)


van Smeden et al. (2016) demonstrated that the "10 EPV" rule had no reliable theoretical or empirical basis as a universal threshold. Performance depends on multiple factors beyond simple ratios.



Riley et al. (2019, 2020) formalised modern sample size calculations for prediction models, shifting the terminology from "events per variable" (EPV) to "events per parameter" (EPP)."events per parameterâ€ This distinction matters:







EPP is preferred because "parameter" is unambiguous, and a 4-level categorical variable clearly requires three parameters, not one.







---


## 3. The Fundamental Tension in Prediction Modelling


Every prediction model requires data to reveal patterns. However, data have finite information content; they can reliably teach a limited number of "lessons" before the model begins fitting noise rather than signal.









~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚   <strong>MORE FEATURES </strong> â”€â”€â”€â”€â”€â”€â”€â–º  More potential patterns to discover          â”‚
â”‚        â”‚                                                                â”‚
â”‚        â”‚                   <strong>BUT ALSO</strong>                                     â”‚
â”‚        â–¼                                                                â”‚
â”‚   <strong>MORE PARAMETERS </strong>â”€â”€â”€â”€â”€â”€â–º  More &quot;lessons&quot; the data must teach           â”‚
â”‚        â”‚                                                                â”‚
â”‚        â”‚                   <strong>WHICH MEANS</strong>                                  â”‚
â”‚        â–¼                                                                â”‚
â”‚   <strong>HIGHER RISK</strong> â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â–º  Learning noise instead of signal             â”‚
â”‚                            (overfitting)                                â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚   \textbf{MORE FEATURES } â”€â”€â”€â”€â”€â”€â”€â–º  More potential patterns to discover          â”‚
â”‚        â”‚                                                                â”‚
â”‚        â”‚                   \textbf{BUT ALSO}                                     â”‚
â”‚        â–¼                                                                â”‚
â”‚   \textbf{MORE PARAMETERS }â”€â”€â”€â”€â”€â”€â–º  More "lessons" the data must teach           â”‚
â”‚        â”‚                                                                â”‚
â”‚        â”‚                   \textbf{WHICH MEANS}                                  â”‚
â”‚        â–¼                                                                â”‚
â”‚   \textbf{HIGHER RISK} â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â–º  Learning noise instead of signal             â”‚
â”‚                            (overfitting)                                â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
\end{Verbatim}
~~~








The methodological literature frames this as a sample size problem: 


- _How much data are required for a given model complexity?_

However, the question can be inverted, given the data available: 


- _how much model complexity could researchers support_
- _how much are they researchers actually using_

---


## 4. Why Events Determine Learning Capacity (Not Total N)


For binary outcomes (yes or no), the effective sample size is determined by the number of outcome events, the less frequent category (either yes or no being less frequent), not the total number of participants or outcome events.outcome events, 



### 4.1 Intuition


Consider learning to distinguish between people who develop a rare disease and those who do not.





~~~{=html}
<pre class="notion-ascii-diagram"><code><strong>Scenario A: Common outcome (50% prevalence, 50% have the disease)</strong>
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹ â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹                       â”‚
â”‚  â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹ â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹                       â”‚
â”‚                                                                â”‚
â”‚  N = 40    Events (â—) = 20    Non-events (â—‹) = 20              â”‚
â”‚                                                                â”‚
â”‚  <strong>Abundant examples in both groups</strong>                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

<strong>Scenario B: Rare outcome (5% prevalence, 5% have the disease)</strong>
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹                   â”‚
â”‚  â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â— â— â—‹ â—‹                   â”‚
â”‚                                                            â”‚
â”‚  N = 40    Events (â—) = 2     Non-events (â—‹) = 38          â”‚
â”‚                                                            â”‚
â”‚  <strong>Only 2 examples of the outcome to learn from </strong>             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
\textbf{Scenario A: Common outcome (50% prevalence, 50% have the disease)}
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹ â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹                       â”‚
â”‚  â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹ â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹                       â”‚
â”‚                                                                â”‚
â”‚  N = 40    Events (â—) = 20    Non-events (â—‹) = 20              â”‚
â”‚                                                                â”‚
â”‚  \textbf{Abundant examples in both groups}                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

\textbf{Scenario B: Rare outcome (5% prevalence, 5% have the disease)}
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹                   â”‚
â”‚  â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â— â— â—‹ â—‹                   â”‚
â”‚                                                            â”‚
â”‚  N = 40    Events (â—) = 2     Non-events (â—‹) = 38          â”‚
â”‚                                                            â”‚
â”‚  \textbf{Only 2 examples of the outcome to learn from }             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
\end{Verbatim}
~~~




In Scenario B, despite N=40, the learning capacity is constrained by only two events. With only 2 events to learn from, the model cannot reliably estimate many parameters



âˆ´ lower prevalence, have the disease, directly limits the number of features that can be safely included.







### 4.2 Mathematical Basis


Riley et al. (2019, 2020) formalised this: the number of events bounds the number of parameters that can be estimated with acceptable shrinkage (i.e. without coefficients being systematically too extreme).



---


## 5. The Feature-Parameter Distinction


A foundational point in prediction modelling methodology is that the cost of a model is measured in parameters, not features (Riley et al., 2019; Harrell, 2015).  The mapping was not performed in a 1:1 ratio.s Whether this distinction is consistently made explicit in UK Biobank prediction papers remains an empirical question.



### 5.1 Parameter Expansion Rules




~~~{=html}
<pre class="notion-ascii-diagram"><code><strong>FEATURE TYPE                          PARAMETERS REQUIRED</strong>
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

1.<strong>Binary (Yes/No) </strong>                    1 parameter
   e.g., Sex                          â–¶ 1 coefficient

2.<strong>Continuous (linear) </strong>                1 parameter
   e.g., Age in years                 â–¶ 1 coefficient

3.<strong>Continuous (non-linear, spline)</strong>     3â€“5 parameters typically
   e.g., Age with RCS, 4 knots        â–¶ 4 coefficients

4.<strong>Categorical (k levels)  </strong>            (k âˆ’ 1) parameters
   e.g., Smoking: Never/Former/       â–¶ 3 coefficients
         Light/Heavy (4 levels)

5.<strong>Interactions</strong>                        Multiplicative
   e.g., Age Ã— Sex                    â–¶ 1 additional parameter
   e.g., Age (spline) Ã— Sex           â–¶ 4 additional parameters

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

<strong>REFLECTIVE NOTES:</strong>

<strong>3.Why splines expand parameters:</strong>
A spline allows the effect to curve rather than stay straight. 
&quot;Knots&quot; are points where the curve can bend.

<strong>Linear (1 param): </strong>    <strong>Spline, 4 knots (3 params):</strong>
                      
Risk     â•±            Risk        â•±
 â”‚     â•±               â”‚       â•±â”€â”€
 â”‚   â•±                 â”‚    â•±â”€â”€
 â”‚ â•±                   â”‚  â•±
 â””â”€â”€â”€â”€â”€â”€ Age           â””â”€â”€â”€â”€â”€â”€ Age

Same slope             Slope changes at
everywhere             each knot

The rule: parameters = knots - 1

<strong>3 knots</strong><strong> </strong>â–¶<strong> </strong><strong>2 parameters
4 knots</strong><strong> </strong>â–¶ <strong>3 parameters
5 knots</strong><strong> </strong>â–¶<strong> </strong><strong>4 parameters</strong>


<strong>5.Why interactions multiply:</strong>
An interaction asks &quot;does the effect of A change depending on B?&quot;

<strong>5.1 Age Ã— Sex (both simple):</strong>
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
One parameter for age. The interaction asks:
&quot;Is the slope different for men vs women?&quot;

â–¶ 1 extra parameter (adjust slope if male)


<strong>5.2 Age (spline) Ã— Sex</strong>
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Three parameters for age (the curve shape). The interaction asks:
&quot;Is the entire curve shape different for men vs women?&quot;

â–¶ 3 extra parameters (adjust each bend if male)

<strong>The rule: multiply the parameters in each term.</strong>

1 (age linear) Ã— 1 (sex) = 1 interaction parameter
3 (age spline) Ã— 1 (sex) = 3 interaction parameters
3 (age spline) Ã— 3 (BMI spline) = 9 interaction parameters
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
\textbf{FEATURE TYPE                          PARAMETERS REQUIRED}
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

1.\textbf{Binary (Yes/No) }                    1 parameter
   e.g., Sex                          â–¶ 1 coefficient

2.\textbf{Continuous (linear) }                1 parameter
   e.g., Age in years                 â–¶ 1 coefficient

3.\textbf{Continuous (non-linear, spline)}     3â€“5 parameters typically
   e.g., Age with RCS, 4 knots        â–¶ 4 coefficients

4.\textbf{Categorical (k levels)  }            (k âˆ’ 1) parameters
   e.g., Smoking: Never/Former/       â–¶ 3 coefficients
         Light/Heavy (4 levels)

5.\textbf{Interactions}                        Multiplicative
   e.g., Age Ã— Sex                    â–¶ 1 additional parameter
   e.g., Age (spline) Ã— Sex           â–¶ 4 additional parameters

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

\textbf{REFLECTIVE NOTES:}

\textbf{3.Why splines expand parameters:}
A spline allows the effect to curve rather than stay straight. 
"Knots" are points where the curve can bend.

\textbf{Linear (1 param): }    \textbf{Spline, 4 knots (3 params):}
                      
Risk     â•±            Risk        â•±
 â”‚     â•±               â”‚       â•±â”€â”€
 â”‚   â•±                 â”‚    â•±â”€â”€
 â”‚ â•±                   â”‚  â•±
 â””â”€â”€â”€â”€â”€â”€ Age           â””â”€â”€â”€â”€â”€â”€ Age

Same slope             Slope changes at
everywhere             each knot

The rule: parameters = knots - 1

\textbf{3 knots}\textbf{ }â–¶\textbf{ }\textbf{2 parameters
4 knots}\textbf{ }â–¶ \textbf{3 parameters
5 knots}\textbf{ }â–¶\textbf{ }\textbf{4 parameters}


\textbf{5.Why interactions multiply:}
An interaction asks "does the effect of A change depending on B?"

\textbf{5.1 Age Ã— Sex (both simple):}
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
One parameter for age. The interaction asks:
"Is the slope different for men vs women?"

â–¶ 1 extra parameter (adjust slope if male)


\textbf{5.2 Age (spline) Ã— Sex}
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Three parameters for age (the curve shape). The interaction asks:
"Is the entire curve shape different for men vs women?"

â–¶ 3 extra parameters (adjust each bend if male)

\textbf{The rule: multiply the parameters in each term.}

1 (age linear) Ã— 1 (sex) = 1 interaction parameter
3 (age spline) Ã— 1 (sex) = 3 interaction parameters
3 (age spline) Ã— 3 (BMI spline) = 9 interaction parameters

\end{Verbatim}
~~~








### 5.2 Worked Example: A "6-Feature" Model


Consider a typical UK Biobank core predictor set.





~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ <strong>                 FEATURE-TO-PARAMETER EXPANSION   </strong>                  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                     â”‚
â”‚  <strong>Feature              Modelling choice         Parameters  </strong>         â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                     â”‚
â”‚<strong>  SIMPLE SPECIFICATION:  </strong>                                            â”‚
â”‚  Age (21022)          Linear                   1                    â”‚
â”‚  Sex (31)             Binary                   1                    â”‚
â”‚  BMI (21001)          Linear                   1                    â”‚
â”‚  Smoking (20116)      4 categories             3                    â”‚
â”‚  HbA1c (30750)        Linear                   1                    â”‚
â”‚  Townsend (189)       Linear                   1                    â”‚
â”‚                                                â”€â”€â”€â”€â”€                â”‚
â”‚                       <strong>Subtotal:                8 parameters </strong>        â”‚
â”‚                                                                     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                     â”‚
â”‚  <strong>REALISTIC SPECIFICATION (with non-linear terms): </strong>                  â”‚
â”‚  Age (21022)          RCS, 4 df                4                    â”‚
â”‚  Sex (31)             Binary                   1                    â”‚
â”‚  BMI (21001)          RCS, 4 df                4                    â”‚
â”‚  Smoking (20116)      4 categories             3                    â”‚
â”‚  HbA1c (30750)        RCS, 4 df                4                    â”‚
â”‚  Townsend (189)       Linear                   1                    â”‚
â”‚                                                â”€â”€â”€â”€â”€                â”‚
â”‚                       <strong>Subtotal:                17 parameters   </strong>     â”‚
â”‚                                                                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

<strong>Observation:</strong> 
&quot;6 features&quot; translates to 8â€“17 parameters depending on modelling 
decisions. Whether papers typically report this expansion is an 
empirical question.
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ \textbf{                 FEATURE-TO-PARAMETER EXPANSION   }                  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                     â”‚
â”‚  \textbf{Feature              Modelling choice         Parameters  }         â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                     â”‚
â”‚\textbf{  SIMPLE SPECIFICATION:  }                                            â”‚
â”‚  Age (21022)          Linear                   1                    â”‚
â”‚  Sex (31)             Binary                   1                    â”‚
â”‚  BMI (21001)          Linear                   1                    â”‚
â”‚  Smoking (20116)      4 categories             3                    â”‚
â”‚  HbA1c (30750)        Linear                   1                    â”‚
â”‚  Townsend (189)       Linear                   1                    â”‚
â”‚                                                â”€â”€â”€â”€â”€                â”‚
â”‚                       \textbf{Subtotal:                8 parameters }        â”‚
â”‚                                                                     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                     â”‚
â”‚  \textbf{REALISTIC SPECIFICATION (with non-linear terms): }                  â”‚
â”‚  Age (21022)          RCS, 4 df                4                    â”‚
â”‚  Sex (31)             Binary                   1                    â”‚
â”‚  BMI (21001)          RCS, 4 df                4                    â”‚
â”‚  Smoking (20116)      4 categories             3                    â”‚
â”‚  HbA1c (30750)        RCS, 4 df                4                    â”‚
â”‚  Townsend (189)       Linear                   1                    â”‚
â”‚                                                â”€â”€â”€â”€â”€                â”‚
â”‚                       \textbf{Subtotal:                17 parameters   }     â”‚
â”‚                                                                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

\textbf{Observation:} 
"6 features" translates to 8â€“17 parameters depending on modelling 
decisions. Whether papers typically report this expansion is an 
empirical question.

\end{Verbatim}
~~~




---


## 6. Defining Events Per Parameter (EPP)


### 6.1 The Core Ratio






$$

\text{EPP} = \frac{\text{Number of outcome events}}{\text{Number of parameters}}

$$


Example: Predicting 5-year mortality



Patients: 1000



Outcome event (Patients died): 80
Predicted variables (parameters): 10



EPP: 80/10 = 8







### 6.2 EPP Thresholds and Their Interpretation




~~~{=html}
<pre class="notion-ascii-diagram"><code><strong>EPP INTERPRETATION (approximate, context-dependent)
</strong>â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

<strong>EPP &lt; 10</strong>        <strong>High overfitting risk</strong>
                Coefficient estimates unstable
                Performance degrades on new data
                âš ï¸  Many published models may operate here

<strong>EPP 10â€“20 </strong>      <strong>Traditional threshold</strong>
                van Smeden et al. (2016): not reliable as
                universal criterion

<strong>EPP 20â€“50</strong>       Generally adequate for logistic regression
                Riley et al. (2019): target shrinkage â‰¥ 0.9

<strong>EPP &gt; 50</strong>        <strong>Comfortable margin</strong>
                Still depends on signal strength (RÂ²) and prevalence

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

<strong>Key point:</strong> EPP is necessary but is not sufficient. The appropriate
           threshold depends on outcome prevalence, expected RÂ²,
           and tolerable shrinkage.
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
\textbf{EPP INTERPRETATION (approximate, context-dependent)
}â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\textbf{EPP < 10}        \textbf{High overfitting risk}
                Coefficient estimates unstable
                Performance degrades on new data
                âš ï¸  Many published models may operate here

\textbf{EPP 10â€“20 }      \textbf{Traditional threshold}
                van Smeden et al. (2016): not reliable as
                universal criterion

\textbf{EPP 20â€“50}       Generally adequate for logistic regression
                Riley et al. (2019): target shrinkage â‰¥ 0.9

\textbf{EPP > 50}        \textbf{Comfortable margin}
                Still depends on signal strength (RÂ²) and prevalence

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\textbf{Key point:} EPP is necessary but is not sufficient. The appropriate
           threshold depends on outcome prevalence, expected RÂ²,
           and tolerable shrinkage.

\end{Verbatim}
~~~








### 6.3 The Riley et al. (2020) Refinement


Modern sample size calculations incorporate:


1. **Outcome prevalence:** determines maximum achievable RÂ²
2. **Anticipated model performance (RÂ²):** weaker signals require more events
3. **Target shrinkage factor:** typically â‰¥ 0.9 (â‰¤10% overfitting)
4. **Precision requirements:** desired confidence interval width

This yields context-specific sample size requirements rather than fixed EPP thresholds.







---


## 7. UK Biobank: Applying the Framework


### 7.1 Baseline Numbers




~~~{=html}
<pre class="notion-ascii-diagram"><code><strong>UK BIOBANK SCALE</strong>
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

<strong>Total participants: </strong>         ~500,000
<strong>Available fields/features: </strong>  ~10,000+ (direct measures, derived, etc.)

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
\textbf{UK BIOBANK SCALE}
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\textbf{Total participants: }         ~500,000
\textbf{Available fields/features: }  ~10,000+ (direct measures, derived, etc.)

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




### 7.2 EPP-Supportable Complexity by Prevalence




~~~{=html}
<pre class="notion-ascii-diagram"><code><strong>MAXIMUM DEFENSIBLE PARAMETERS AT DIFFERENT PREVALENCES</strong>
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

                                      Max parameters at:
<strong>Prevalence    Events (N=500k)       EPP=20         EPP=50</strong>
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
10.0%         50,000                2,500          1,000
5.0%          25,000                1,250          500
1.0%          5,000                 250            100
0.5%          2,500                 125            50
0.1%          500                   25             10
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
<strong>These are UPPER BOUNDS on model complexity given statistical constraints</strong>
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
\textbf{MAXIMUM DEFENSIBLE PARAMETERS AT DIFFERENT PREVALENCES}
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

                                      Max parameters at:
\textbf{Prevalence    Events (N=500k)       EPP=20         EPP=50}
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
10.0%         50,000                2,500          1,000
5.0%          25,000                1,250          500
1.0%          5,000                 250            100
0.5%          2,500                 125            50
0.1%          500                   25             10
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
\textbf{These are UPPER BOUNDS on model complexity given statistical constraints}
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
\end{Verbatim}
~~~










~~~{=html}
<pre class="notion-ascii-diagram"><code><strong>ARE YOU USING TOO FEW OR TOO MANY PARAMETERS?</strong>
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
Safe range                         If using ~50 parameters:
Prevalence       Events            <strong>Min              Max</strong>
                                   <strong>EPP=50          EPP=20</strong>
<strong>% outcome        N=500k         conservative       relaxed       Status   Interpretation</strong>
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
10.0%            50,000            1,000              2,500        ğŸ”´     Wasting data
5.0%             25,000              500              1,250        ğŸ”´     Wasting data
2.0%             10,000              200                500        ğŸ”´     Wasting data
1.0%              5,000              100                250        ğŸ”´     Wasting data
0.5%              2,500               50                125        ğŸŸ¢     Appropriate
0.2%              1,000               20                 50        ğŸŸ¢     At lower bound
0.1%                500               10                 25        ğŸ”´     Overfitting risk
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
ğŸ”´ Outside safe range    ğŸŸ¢ Within safe range

<strong>A fixed ~50-parameter approach only fits outcomes with 0.2â€“0.5% prevalence!!!</strong>
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
\textbf{ARE YOU USING TOO FEW OR TOO MANY PARAMETERS?}
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
Safe range                         If using ~50 parameters:
Prevalence       Events            \textbf{Min              Max}
                                   \textbf{EPP=50          EPP=20}
\textbf{% outcome        N=500k         conservative       relaxed       Status   Interpretation}
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
10.0%            50,000            1,000              2,500        ğŸ”´     Wasting data
5.0%             25,000              500              1,250        ğŸ”´     Wasting data
2.0%             10,000              200                500        ğŸ”´     Wasting data
1.0%              5,000              100                250        ğŸ”´     Wasting data
0.5%              2,500               50                125        ğŸŸ¢     Appropriate
0.2%              1,000               20                 50        ğŸŸ¢     At lower bound
0.1%                500               10                 25        ğŸ”´     Overfitting risk
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
ğŸ”´ Outside safe range    ğŸŸ¢ Within safe range

\textbf{A fixed ~50-parameter approach only fits outcomes with 0.2â€“0.5% prevalence!!!}
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
\end{Verbatim}
~~~








### 7.3 Visual Representation




~~~{=html}
<pre class="notion-ascii-diagram"><code>             <strong>PARAMETER BUDGET BY OUTCOME PREVALENCE</strong>
              (UK Biobank, N â‰ˆ 500,000, EPP = 20)

Parameters
    â”‚
2500â”¤ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ   â—€ 10% prevalence
    â”‚                                                  (50,000 events)
2000â”¤
    â”‚
1500â”¤
    â”‚
1250â”¤ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ              â—€ 5% prevalence
    â”‚                                                  (25,000 events)
1000â”¤
    â”‚
 750â”¤
    â”‚
 500â”¤
    â”‚
 250â”¤ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ                                        â—€ 1% prevalence
    â”‚                                                  (5,000 events)
 125â”¤ â–ˆâ–ˆâ–ˆâ–ˆ                                           â—€ 0.5% prevalence
    â”‚
  25â”¤ â–ˆ                                              â—€ 0.1% prevalence
    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
             \textbf{PARAMETER BUDGET BY OUTCOME PREVALENCE}
              (UK Biobank, N â‰ˆ 500,000, EPP = 20)

Parameters
    â”‚
2500â”¤ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ   â—€ 10% prevalence
    â”‚                                                  (50,000 events)
2000â”¤
    â”‚
1500â”¤
    â”‚
1250â”¤ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ              â—€ 5% prevalence
    â”‚                                                  (25,000 events)
1000â”¤
    â”‚
 750â”¤
    â”‚
 500â”¤
    â”‚
 250â”¤ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ                                        â—€ 1% prevalence
    â”‚                                                  (5,000 events)
 125â”¤ â–ˆâ–ˆâ–ˆâ–ˆ                                           â—€ 0.5% prevalence
    â”‚
  25â”¤ â–ˆ                                              â—€ 0.1% prevalence
    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

\end{Verbatim}
~~~




---


## 8. Inverting the Question: EPP as Diagnostic Tool


### 8.1 The Standard Framing


EPP is conventionally presented as a constraint:


> "Do I have enough events for the features I want to include?"

This protects individual studies from overfitting.



### 8.2 The Investigative Framing


But EPP can equally serve as a diagnostic:


> "Given the events available, why are researchers using so few features?"

This characterises field-wide patterns of feature selection.



### 8.3 The Utilisation Ratio


If we can measure both quantities, we can compute:





~~~{=html}
<pre class="notion-ascii-diagram"><code>                          Parameters actually used
  Utilisation ratio  =   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
                          Parameters supportable (EPP)
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
                          Parameters actually used
  Utilisation ratio  =   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
                          Parameters supportable (EPP)

\end{Verbatim}
~~~




---


## 9. Hypothetical Scenarios


### 9.1 Utilisation Near Capacity




~~~{=html}
<pre class="notion-ascii-diagram"><code><strong>SCENARIO A: Researchers approaching statistical limits</strong>
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

<strong>Study parameters:</strong>
  - Outcome prevalence: 5%
  - Events: 25,000
  - EPP threshold: 20
  - Supportable parameters: 1,250

<strong>Observed:</strong>
  - Parameters used: 1,100 (â‰ˆ 200+ features with expansions)

<strong>Utilisation ratio:</strong> 1,100 / 1,250 = 88%

<strong>Interpretation:</strong>
  Feature selection appears constrained by EPP.
  Researchers are exploring near the statistical limit.
  Underutilisation is NOT occurring.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
\textbf{SCENARIO A: Researchers approaching statistical limits}
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\textbf{Study parameters:}
  - Outcome prevalence: 5%
  - Events: 25,000
  - EPP threshold: 20
  - Supportable parameters: 1,250

\textbf{Observed:}
  - Parameters used: 1,100 (â‰ˆ 200+ features with expansions)

\textbf{Utilisation ratio:} 1,100 / 1,250 = 88%

\textbf{Interpretation:}
  Feature selection appears constrained by EPP.
  Researchers are exploring near the statistical limit.
  Underutilisation is NOT occurring.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
\end{Verbatim}
~~~




### 9.2 Utilisation Far Below Capacity




~~~{=html}
<pre class="notion-ascii-diagram"><code><strong>SCENARIO B: Researchers far below statistical limits
</strong>â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

<strong>Study parameters:</strong>
  - Outcome prevalence: 5%
  - Events: 25,000
  - EPP threshold: 20
  - Supportable parameters: 1,250

<strong>Observed:</strong>
  - Parameters used: 50 (â‰ˆ 20â€“30 features)

<strong>Utilisation ratio:</strong> 50 / 1,250 = 4%

<strong>Interpretation:</strong>
  Researchers are using only 4% of their statistical budget.
  The constraint is NOT EPP.
  Something else is limiting feature exploration.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
\textbf{SCENARIO B: Researchers far below statistical limits
}â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\textbf{Study parameters:}
  - Outcome prevalence: 5%
  - Events: 25,000
  - EPP threshold: 20
  - Supportable parameters: 1,250

\textbf{Observed:}
  - Parameters used: 50 (â‰ˆ 20â€“30 features)

\textbf{Utilisation ratio:} 50 / 1,250 = 4%

\textbf{Interpretation:}
  Researchers are using only 4% of their statistical budget.
  The constraint is NOT EPP.
  Something else is limiting feature exploration.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




---


## 10. Possible Interpretations of Low Utilisation (If Observed)


The following hypotheses would become relevant if systematic analysis revealed UK Biobank studies consistently operate far below EPP capacity. These are interpretive frameworks, not established findings.



### 10.1 Possible Interpretation: Convergence on a "Core" Feature Set




~~~{=html}
<pre class="notion-ascii-diagram"><code>        <strong>10,000+ available UK Biobank features </strong>â–ˆ
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                        â”‚
â”‚  â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘  â”‚
â”‚  â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘  â”‚
â”‚  â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘  â”‚
â”‚  â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–“â–“â–“â–“â–“â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚                                                        â”‚
â”‚  â–¡ UK Biobank fields (features)                        â”‚
â”‚  â–‘ Cannot use (~18%): 180 dots                         â”‚
â”‚  â–ˆ Can use (~82%): 820 dots                            â”‚
â”‚  â–“ Hypothetical core: 5 dots (50 features)             â”‚
â”‚                                                        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

<strong>If such a pattern were found empirically, possible explanations might include:</strong>

  â€¢ These features are genuinely most predictive for most outcomes
  â€¢ These features are most accessible (complete, easy to process)
  â€¢ Citation/replication practices reinforce &quot;established&quot; predictors
  â€¢ Methods sections are adapted from prior work
  â€¢ Reviewer expectations favour familiar features

<strong>Each explanation would require separate investigation.</strong></code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
        \textbf{10,000+ available UK Biobank features }â–ˆ
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                        â”‚
â”‚  â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘  â”‚
â”‚  â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘  â”‚
â”‚  â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘  â”‚
â”‚  â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚  â–“â–“â–“â–“â–“â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â”‚
â”‚                                                        â”‚
â”‚  â–¡ UK Biobank fields (features)                        â”‚
â”‚  â–‘ Cannot use (~18%): 180 dots                         â”‚
â”‚  â–ˆ Can use (~82%): 820 dots                            â”‚
â”‚  â–“ Hypothetical core: 5 dots (50 features)             â”‚
â”‚                                                        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

\textbf{If such a pattern were found empirically, possible explanations might include:}

  â€¢ These features are genuinely most predictive for most outcomes
  â€¢ These features are most accessible (complete, easy to process)
  â€¢ Citation/replication practices reinforce "established" predictors
  â€¢ Methods sections are adapted from prior work
  â€¢ Reviewer expectations favour familiar features

\textbf{Each explanation would require separate investigation.}
\end{Verbatim}
~~~




### 10.2 Possible Interpretation: Outcome-Feature Mismatch




~~~{=html}
<pre class="notion-ascii-diagram"><code><strong>EXPECTED PATTERN (if feature selection is outcome-driven):</strong>
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Different outcomes should draw on different feature pools

<strong>Cardiovascular outcomes: </strong>             <strong>Neurological outcomes:</strong>
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”          â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Lipids                  â”‚          â”‚ Cognitive tests         â”‚
â”‚ Blood pressure          â”‚          â”‚ Brain imaging           â”‚
â”‚ ECG measures            â”‚          â”‚ Reaction time           â”‚
â”‚ Exercise capacity       â”‚          â”‚ Mood/sleep              â”‚
â”‚ Smoking, diet           â”‚          â”‚ Education               â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜          â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
       <strong> Distinct feature pools with limited overlap</strong>


<strong>ALTERNATIVE PATTERN (if a core exists):</strong>
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Different outcomes draw on same feature pool

<strong>Cardiovascular outcomes:              Neurological outcomes:</strong>
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”          â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Age, Sex, BMI           â”‚          â”‚ Age, Sex, BMI           â”‚
â”‚ Smoking status          â”‚          â”‚ Smoking status          â”‚
â”‚ Townsend index          â”‚          â”‚ Townsend index          â”‚
â”‚ Blood pressure          â”‚          â”‚ Blood pressure          â”‚
â”‚ ...                     â”‚          â”‚ ...                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜          â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
        <strong>Near-identical despite distinct clinical domains</strong>

If so: Are outcome-specific features being systematically ignored?

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
\textbf{EXPECTED PATTERN (if feature selection is outcome-driven):}
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Different outcomes should draw on different feature pools

\textbf{Cardiovascular outcomes: }             \textbf{Neurological outcomes:}
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”          â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Lipids                  â”‚          â”‚ Cognitive tests         â”‚
â”‚ Blood pressure          â”‚          â”‚ Brain imaging           â”‚
â”‚ ECG measures            â”‚          â”‚ Reaction time           â”‚
â”‚ Exercise capacity       â”‚          â”‚ Mood/sleep              â”‚
â”‚ Smoking, diet           â”‚          â”‚ Education               â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜          â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
       \textbf{ Distinct feature pools with limited overlap}


\textbf{ALTERNATIVE PATTERN (if a core exists):}
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Different outcomes draw on same feature pool

\textbf{Cardiovascular outcomes:              Neurological outcomes:}
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”          â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Age, Sex, BMI           â”‚          â”‚ Age, Sex, BMI           â”‚
â”‚ Smoking status          â”‚          â”‚ Smoking status          â”‚
â”‚ Townsend index          â”‚          â”‚ Townsend index          â”‚
â”‚ Blood pressure          â”‚          â”‚ Blood pressure          â”‚
â”‚ ...                     â”‚          â”‚ ...                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜          â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
        \textbf{Near-identical despite distinct clinical domains}

If so: Are outcome-specific features being systematically ignored?

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




### 10.3 Possible Interpretation: Feature Selection Misalignment


EPP constrains how many parameters can be estimated. It says nothing about whether the right parameters are being estimated.





~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚ <strong> Two models, both statistically adequate (EPP = 50)    </strong>                 â”‚
â”‚                                                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚
â”‚  â”‚ <strong>MODEL A: Features with genuine predictive/causal relationships</strong>  â”‚    â”‚
â”‚  â”‚                                                                 â”‚    â”‚ 
â”‚  â”‚   â–¶ Good discrimination (AUC ~ 0.80)                            â”‚    â”‚
â”‚  â”‚   â–¶ Stable calibration across populations                       â”‚    â”‚
â”‚  â”‚   â–¶ Transportable to external cohorts                           â”‚    â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚
â”‚                                                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚
â”‚  â”‚ <strong>MODEL B: Features that are proxies, confounded, or local </strong>       â”‚    â”‚
â”‚  â”‚                                                                 â”‚    â”‚
â”‚  â”‚   â–¶ Modest discrimination (AUC ~ 0.65)                          â”‚    â”‚
â”‚  â”‚   â–¶ Calibration degrades on external validation                 â”‚    â”‚
â”‚  â”‚   â–¶ Poor transportability                                       â”‚    â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚
â”‚                                                                         â”‚
â”‚  <strong>EPP CANNOT DISTINGUISH BETWEEN A AND B </strong>                                â”‚
â”‚                                                                         â”‚
â”‚  If researchers consistently select from a narrow pool, they may:       â”‚
â”‚    â€¢ Miss features that would improve prediction                        â”‚
â”‚    â€¢ Include features by convention rather than evidence                â”‚
â”‚    â€¢ Fail to consider disease-specific biology                          â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚ \textbf{ Two models, both statistically adequate (EPP = 50)    }                 â”‚
â”‚                                                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚
â”‚  â”‚ \textbf{MODEL A: Features with genuine predictive/causal relationships}  â”‚    â”‚
â”‚  â”‚                                                                 â”‚    â”‚ 
â”‚  â”‚   â–¶ Good discrimination (AUC ~ 0.80)                            â”‚    â”‚
â”‚  â”‚   â–¶ Stable calibration across populations                       â”‚    â”‚
â”‚  â”‚   â–¶ Transportable to external cohorts                           â”‚    â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚
â”‚                                                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚
â”‚  â”‚ \textbf{MODEL B: Features that are proxies, confounded, or local }       â”‚    â”‚
â”‚  â”‚                                                                 â”‚    â”‚
â”‚  â”‚   â–¶ Modest discrimination (AUC ~ 0.65)                          â”‚    â”‚
â”‚  â”‚   â–¶ Calibration degrades on external validation                 â”‚    â”‚
â”‚  â”‚   â–¶ Poor transportability                                       â”‚    â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚
â”‚                                                                         â”‚
â”‚  \textbf{EPP CANNOT DISTINGUISH BETWEEN A AND B }                                â”‚
â”‚                                                                         â”‚
â”‚  If researchers consistently select from a narrow pool, they may:       â”‚
â”‚    â€¢ Miss features that would improve prediction                        â”‚
â”‚    â€¢ Include features by convention rather than evidence                â”‚
â”‚    â€¢ Fail to consider disease-specific biology                          â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
\end{Verbatim}
~~~




---


## 11. Medical Ontologies as Independent Benchmark


Medical ontologies (MONDO, HPO, EFO, ICD-10, SNOMED-CT) encode structured domain knowledge:


- Which biological processes relate to which diseases
- Which measurements reflect which physiological states
- Which features _should_ be relevant based on clinical/biological reasoning

This provides an independent reference point, separate from what papers actually use.



### 11.1 Example: Type 2 Diabetes




~~~{=html}
<pre class="notion-ascii-diagram"><code><strong>ONTOLOGY-DERIVED EXPECTED FEATURES FOR &#39;Type 2 Diabetes&#39; (MONDO:0005148)
</strong>â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Domain knowledge suggests these feature categories are relevant:

â”œâ”€â”€ <strong>Metabolic markers</strong>
â”‚   â”œâ”€â”€ HbA1c
â”‚   â”œâ”€â”€ Fasting glucose
â”‚   â”œâ”€â”€ Insulin levels
â”‚   â”œâ”€â”€ C-peptide
â”‚   â””â”€â”€ Lipid panel (TG, HDL, LDL)
â”‚
â”œâ”€â”€ <strong>Anthropometric</strong>
â”‚   â”œâ”€â”€ BMI
â”‚   â”œâ”€â”€ Waist circumference
â”‚   â”œâ”€â”€ Waist-hip ratio
â”‚   â””â”€â”€ Body fat percentage
â”‚
â”œâ”€â”€ <strong>Genetic/familial</strong>
â”‚   â”œâ”€â”€ TCF7L2 variants
â”‚   â”œâ”€â”€ Polygenic risk scores
â”‚   â””â”€â”€ Family history
â”‚
â”œâ”€â”€ <strong>Lifestyle</strong>
â”‚   â”œâ”€â”€ Physical activity measures
â”‚   â”œâ”€â”€ Diet composition
â”‚   â”œâ”€â”€ Sleep duration/quality
â”‚   â””â”€â”€ Alcohol consumption
â”‚
â”œâ”€â”€ <strong>Comorbidity indicators</strong>
â”‚   â”œâ”€â”€ Blood pressure
â”‚   â”œâ”€â”€ Kidney function (eGFR, creatinine)
â”‚   â”œâ”€â”€ Liver function (ALT, GGT)
â”‚   â””â”€â”€ Inflammatory markers (CRP)
â”‚
â””â”€â”€ <strong>Sociodemographic</strong>
    â”œâ”€â”€ Age
    â”œâ”€â”€ Sex
    â”œâ”€â”€ Ethnicity
    â””â”€â”€ Deprivation indices

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

<strong>Empirical question:</strong> 
What features do &#39;Type 2 Diabetes&#39; prediction papers actually use?
Gap between ontology-suggested and actually-used = potential underutilisation

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
\textbf{ONTOLOGY-DERIVED EXPECTED FEATURES FOR 'Type 2 Diabetes' (MONDO:0005148)
}â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Domain knowledge suggests these feature categories are relevant:

â”œâ”€â”€ \textbf{Metabolic markers}
â”‚   â”œâ”€â”€ HbA1c
â”‚   â”œâ”€â”€ Fasting glucose
â”‚   â”œâ”€â”€ Insulin levels
â”‚   â”œâ”€â”€ C-peptide
â”‚   â””â”€â”€ Lipid panel (TG, HDL, LDL)
â”‚
â”œâ”€â”€ \textbf{Anthropometric}
â”‚   â”œâ”€â”€ BMI
â”‚   â”œâ”€â”€ Waist circumference
â”‚   â”œâ”€â”€ Waist-hip ratio
â”‚   â””â”€â”€ Body fat percentage
â”‚
â”œâ”€â”€ \textbf{Genetic/familial}
â”‚   â”œâ”€â”€ TCF7L2 variants
â”‚   â”œâ”€â”€ Polygenic risk scores
â”‚   â””â”€â”€ Family history
â”‚
â”œâ”€â”€ \textbf{Lifestyle}
â”‚   â”œâ”€â”€ Physical activity measures
â”‚   â”œâ”€â”€ Diet composition
â”‚   â”œâ”€â”€ Sleep duration/quality
â”‚   â””â”€â”€ Alcohol consumption
â”‚
â”œâ”€â”€ \textbf{Comorbidity indicators}
â”‚   â”œâ”€â”€ Blood pressure
â”‚   â”œâ”€â”€ Kidney function (eGFR, creatinine)
â”‚   â”œâ”€â”€ Liver function (ALT, GGT)
â”‚   â””â”€â”€ Inflammatory markers (CRP)
â”‚
â””â”€â”€ \textbf{Sociodemographic}
    â”œâ”€â”€ Age
    â”œâ”€â”€ Sex
    â”œâ”€â”€ Ethnicity
    â””â”€â”€ Deprivation indices

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\textbf{Empirical question:} 
What features do 'Type 2 Diabetes' prediction papers actually use?
Gap between ontology-suggested and actually-used = potential underutilisation

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




---


## 12. A Testable Research Framework - Future Work


The EPP framework enables a specific, quantitative research programme:



### 12.1 Three Quantities to Compare




~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  For each UK Biobank prediction study, measure:                         â”‚
â”‚                                                                         â”‚
â”‚   <strong> (a) STATISTICAL CAPACITY  </strong>                                           â”‚
â”‚        Parameters supportable given event count and EPP threshold       â”‚
â”‚        â–¶ Calculated from: events / EPP_threshold                        â”‚
â”‚                                                                         â”‚
â”‚    <strong>(b) ACTUAL UTILISATION </strong>                                              â”‚
â”‚        Parameters actually used in the published model                  â”‚
â”‚        â–¶ Extracted from: methods sections, supplementary materials      â”‚
â”‚                                                                         â”‚
â”‚   <strong> (c) DOMAIN EXPECTATION  </strong>                                             â”‚
â”‚        Features suggested by medical ontologies for that outcome        â”‚
â”‚        â–¶ Derived from: MONDO, HPO, EFO mappings to UKB fields           â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  For each UK Biobank prediction study, measure:                         â”‚
â”‚                                                                         â”‚
â”‚   \textbf{ (a) STATISTICAL CAPACITY  }                                           â”‚
â”‚        Parameters supportable given event count and EPP threshold       â”‚
â”‚        â–¶ Calculated from: events / EPP_threshold                        â”‚
â”‚                                                                         â”‚
â”‚    \textbf{(b) ACTUAL UTILISATION }                                              â”‚
â”‚        Parameters actually used in the published model                  â”‚
â”‚        â–¶ Extracted from: methods sections, supplementary materials      â”‚
â”‚                                                                         â”‚
â”‚   \textbf{ (c) DOMAIN EXPECTATION  }                                             â”‚
â”‚        Features suggested by medical ontologies for that outcome        â”‚
â”‚        â–¶ Derived from: MONDO, HPO, EFO mappings to UKB fields           â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
\end{Verbatim}
~~~




### 12.2 Visual Comparison




~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                      â”‚
â”‚    <strong>    (a)             (c)              (b)   </strong>       â”‚
â”‚       â”Œâ”€â”€â”€â”           â”Œâ”€â”€â”€â”            â”Œâ”€â”€â”€â”         â”‚
â”‚       â”‚   â”‚           â”‚   â”‚            â”‚   â”‚         â”‚
â”‚       â”‚   â”‚           â”‚   â”‚            â”‚   â”‚         â”‚
â”‚       â”‚   â”‚           â”‚   â”‚            â”‚   â”‚         â”‚
â”‚       â”‚   â”‚           â”‚   â”‚            â”‚   â”‚         â”‚
â”‚       â”‚   â”‚           â”‚   â”‚            â”‚   â”‚         â”‚
â”‚       â”‚   â”‚           â”‚   â”‚            â”‚   â”‚         â”‚
â”‚       â”‚   â”‚           â”‚   â”‚            â”‚   â”‚         â”‚
â”‚       â””â”€â”€â”€â”˜           â””â”€â”€â”€â”˜            â””â”€â”€â”€â”˜         â”‚
â”‚ <strong>   Statistical       Ontology-        Actually       â”‚
â”‚     capacity        suggested           used     </strong>    â”‚
â”‚                                                      â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                      â”‚
â”‚    \textbf{    (a)             (c)              (b)   }       â”‚
â”‚       â”Œâ”€â”€â”€â”           â”Œâ”€â”€â”€â”            â”Œâ”€â”€â”€â”         â”‚
â”‚       â”‚   â”‚           â”‚   â”‚            â”‚   â”‚         â”‚
â”‚       â”‚   â”‚           â”‚   â”‚            â”‚   â”‚         â”‚
â”‚       â”‚   â”‚           â”‚   â”‚            â”‚   â”‚         â”‚
â”‚       â”‚   â”‚           â”‚   â”‚            â”‚   â”‚         â”‚
â”‚       â”‚   â”‚           â”‚   â”‚            â”‚   â”‚         â”‚
â”‚       â”‚   â”‚           â”‚   â”‚            â”‚   â”‚         â”‚
â”‚       â”‚   â”‚           â”‚   â”‚            â”‚   â”‚         â”‚
â”‚       â””â”€â”€â”€â”˜           â””â”€â”€â”€â”˜            â””â”€â”€â”€â”˜         â”‚
â”‚ \textbf{   Statistical       Ontology-        Actually       â”‚
â”‚     capacity        suggested           used     }    â”‚
â”‚                                                      â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

\end{Verbatim}
~~~




### 12.3 Interpretation Matrix




~~~{=html}
<pre class="notion-ascii-diagram"><code><strong>PATTERN                              INTERPRETATION</strong>
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

<strong>(b) â‰ˆ (a) </strong>                       Researchers operating at statistical
                                 limits. No evidence of underutilisation.

<strong>(b) &lt;&lt; (a) and (b) &lt;&lt; (c) </strong>       Systematic underutilisation.
                                 Statistical capacity is unused.
                                 Domain-relevant features ignored.
                                 â†’ STRONGEST EVIDENCE FOR PROBLEM

<strong>(b) &lt;&lt; (a) but (b) â‰ˆ (c) </strong>        Conservative but domain-appropriate.
                                 Using fewer features than possible,
                                 but aligned with domain knowledge.

<strong>(b) â‰ˆ (a) but (b) â‰  (c) </strong>         EPP-constrained but potentially
                                 mis-specified. Operating at limits
                                 but feature choice may not match
                                 domain expectations.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
\textbf{PATTERN                              INTERPRETATION}
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\textbf{(b) â‰ˆ (a) }                       Researchers operating at statistical
                                 limits. No evidence of underutilisation.

\textbf{(b) << (a) and (b) << (c) }       Systematic underutilisation.
                                 Statistical capacity is unused.
                                 Domain-relevant features ignored.
                                 â†’ STRONGEST EVIDENCE FOR PROBLEM

\textbf{(b) << (a) but (b) â‰ˆ (c) }        Conservative but domain-appropriate.
                                 Using fewer features than possible,
                                 but aligned with domain knowledge.

\textbf{(b) â‰ˆ (a) but (b) â‰  (c) }         EPP-constrained but potentially
                                 mis-specified. Operating at limits
                                 but feature choice may not match
                                 domain expectations.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




---


## 13. Conditional Implications


### 13.1 What Finding a "Core" Would Mean (If Found)


The following implications are conditional on empirical findings:







If analysis were to reveal:


- A small set of features (~50) accounts for majority of feature usage
- This set is stable across diverse outcomes (cardiovascular, neurological, etc.)
- Studies operate far below EPP capacity





Then this would suggest:


- Feature selection is not EPP-constrained
- Convergence on similar features occurs despite statistical capacity for divergence
- The pattern may reflect methodological, practical, or sociological factors rather than outcome-specific reasoning

Whether such a pattern exists is an empirical question.







### 13.2 What This Framework Can and Cannot Address




~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  <strong>This framework can potentially show: </strong>                                  â”‚
â”‚    â€¢ Gap between EPP capacity and actual utilisation                    â”‚
â”‚    â€¢ Whether feature usage varies by outcome type                       â”‚
â”‚    â€¢ Degree of convergence on common features (if any)                  â”‚
â”‚                                                                         â”‚
â”‚  <strong>This framework cannot show: </strong>                                           â”‚
â”‚    â€¢ That unused features would improve prediction                      â”‚
â”‚    â€¢ That commonly used features are suboptimal                         â”‚
â”‚    â€¢ Causal relationships between features and outcomes                 â”‚
â”‚    â€¢ Whether current practice is &quot;wrong&quot;                                â”‚
â”‚                                                                         â”‚
â”‚  <strong>The framework is DIAGNOSTIC and DESCRIPTIVE </strong>                           â”‚
â”‚  It characterises patterns; it does not prescribe solutions             â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  \textbf{This framework can potentially show: }                                  â”‚
â”‚    â€¢ Gap between EPP capacity and actual utilisation                    â”‚
â”‚    â€¢ Whether feature usage varies by outcome type                       â”‚
â”‚    â€¢ Degree of convergence on common features (if any)                  â”‚
â”‚                                                                         â”‚
â”‚  \textbf{This framework cannot show: }                                           â”‚
â”‚    â€¢ That unused features would improve prediction                      â”‚
â”‚    â€¢ That commonly used features are suboptimal                         â”‚
â”‚    â€¢ Causal relationships between features and outcomes                 â”‚
â”‚    â€¢ Whether current practice is "wrong"                                â”‚
â”‚                                                                         â”‚
â”‚  \textbf{The framework is DIAGNOSTIC and DESCRIPTIVE }                           â”‚
â”‚  It characterises patterns; it does not prescribe solutions             â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
\end{Verbatim}
~~~




---


## 14. Summary: What EPP Reveals If a Core Feature Set Exists


The central insight emerges when we combine EPP with the possibility of a core feature set:





~~~{=html}
<pre class="notion-ascii-diagram"><code>â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
<strong>THE KEY REFRAMING</strong>
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

IF UK Biobank prediction studies converge on ~50 core features
regardless of outcome...

<strong>THEN EPP is NOT the constraint.</strong>

A study with 25,000 events (5% prevalence) could support 1,250+
parameters at EPP=20. That&#39;s capacity for hundreds of features.

Yet if researchers consistently use ~50 features across diverse
outcomes, they&#39;re operating at ~4% of statistical capacity.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
<strong>WHAT THIS WOULD MEAN</strong>
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

<strong>The problem is not:</strong>
  &quot;We can&#39;t use more features because of sample size constraints&quot;

<strong>The problem (if a core exists) may be:</strong>
  &quot;We use the SAME features regardless of how many we COULD use&quot;

<strong>This is a fundamentally different issue:</strong>
  â€¢ Not a statistical limitation
  â€¢ Not an EPP constraint
  â€¢ Potentially a behavioural/methodological/sociological pattern

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
<strong>WHAT EPP TELLS US IN THIS SCENARIO</strong>
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

EPP becomes the counterfactual that exposes the pattern:

  &quot;You had statistical budget for 1,250 parameters.
   You used 50.
   The same 50 as studies predicting entirely different outcomes.

   EPP wasn&#39;t your constraint. What was?&quot;

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
\textbf{THE KEY REFRAMING}
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

IF UK Biobank prediction studies converge on ~50 core features
regardless of outcome...

\textbf{THEN EPP is NOT the constraint.}

A study with 25,000 events (5% prevalence) could support 1,250+
parameters at EPP=20. That's capacity for hundreds of features.

Yet if researchers consistently use ~50 features across diverse
outcomes, they're operating at ~4% of statistical capacity.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
\textbf{WHAT THIS WOULD MEAN}
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

\textbf{The problem is not:}
  "We can't use more features because of sample size constraints"

\textbf{The problem (if a core exists) may be:}
  "We use the SAME features regardless of how many we COULD use"

\textbf{This is a fundamentally different issue:}
  â€¢ Not a statistical limitation
  â€¢ Not an EPP constraint
  â€¢ Potentially a behavioural/methodological/sociological pattern

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
\textbf{WHAT EPP TELLS US IN THIS SCENARIO}
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

EPP becomes the counterfactual that exposes the pattern:

  "You had statistical budget for 1,250 parameters.
   You used 50.
   The same 50 as studies predicting entirely different outcomes.

   EPP wasn't your constraint. What was?"

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
\end{Verbatim}
~~~




### 14.1 The Research Question, Restated




~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  This is not about whether researchers use TOO MANY or TOO FEW features.â”‚
â”‚  EPP already addresses that question.                                   â”‚
â”‚                                                                         â”‚
â”‚  This is about whether researchers use THE SAME features                â”‚
â”‚  across outcomes where:                                                 â”‚
â”‚                                                                         â”‚
â”‚    (a) EPP would permit far more exploration                            â”‚
â”‚    (b) Domain knowledge suggests different features are relevant        â”‚
â”‚    (c) The convergence cannot be explained by statistical constraints   â”‚
â”‚                                                                         â”‚
â”‚  If such a pattern exists, it suggests feature selection in UK Biobank  â”‚
â”‚  research may be driven by factors other than outcome-specific          â”‚
â”‚  statistical or clinical reasoning.                                     â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  This is not about whether researchers use TOO MANY or TOO FEW features.â”‚
â”‚  EPP already addresses that question.                                   â”‚
â”‚                                                                         â”‚
â”‚  This is about whether researchers use THE SAME features                â”‚
â”‚  across outcomes where:                                                 â”‚
â”‚                                                                         â”‚
â”‚    (a) EPP would permit far more exploration                            â”‚
â”‚    (b) Domain knowledge suggests different features are relevant        â”‚
â”‚    (c) The convergence cannot be explained by statistical constraints   â”‚
â”‚                                                                         â”‚
â”‚  If such a pattern exists, it suggests feature selection in UK Biobank  â”‚
â”‚  research may be driven by factors other than outcome-specific          â”‚
â”‚  statistical or clinical reasoning.                                     â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
\end{Verbatim}
~~~




### 14.2 Cautionary Notes


These notes represent a conceptual framework, not empirical findings. The claims above are conditional:


- **IF** a core feature set exists (empirical question requiring systematic review)
- **IF** utilisation is consistently low relative to EPP capacity (requires calculation across studies)
- **IF** the same features appear across diverse outcomes (requires cross-domain comparison)

Each conditional requires evidence. The framework provides the logic for interpreting such evidence if found.







---


## References


Aschard, H., Guillemot, V., Vilhjalmsson, B., et al. (2017) 'Covariate selection for association screening in multiphenotype genetic studies', Nature Genetics, 49, pp.1789â€“1795.



Canbek, G., Taskaya Temizel, T., & Sagiroglu, S. (2022) 'Gaining insights in datasets in the shade of "garbage in, garbage out" rationale: Feature space distribution fitting', WIREs Data Mining and Knowledge Discovery, 12(3):e1456.



Collins, G.S., Moons, K.G.M., Dhiman, P., et al. (2024) 'TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods', BMJ, 385:e078378.



Dor, E., et al. (2023) 'Selecting Covariates for Genome-Wide Association Studies', bioRxiv, 2023.02.07.527425.



Efroymson, M.A. (1960) 'Multiple regression analysis', in Ralston, A. and Wilf, H.S. (eds.) Mathematical Methods for Digital Computers. New York: Wiley, pp.191â€“203.



Flom, P.L. & Cassell, D.L. (2007) 'Stopping stepwise: Why stepwise and similar selection methods are bad, and what you should use', NESUG 2007.



Guyon, I. & Elisseeff, A. (2003) 'An introduction to variable and feature selection', Journal of Machine Learning Research, 3, pp.1157â€“1182.



Harrell, F.E. (2015) Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. 2nd edn. New York: Springer.



Martin, G.P., Riley, R.D., Ensor, J., & Grant, S.W. (2025) 'Statistical primer: sample size considerations for developing and validating clinical prediction models', European Journal of Cardio-Thoracic Surgery, 67(5):ezaf142.



Moons, K.G.M., Damen, J.A.A., Kaul, T., et al. (2025) 'PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods', BMJ, 388:e082505.



Peduzzi, P., Concato, J., Kemper, E., Holford, T.R. & Feinstein, A.R. (1996) 'A simulation study of the number of events per variable in logistic regression analysis', Journal of Clinical Epidemiology, 49(12), pp.1373â€“1379.



Riley, R.D., Snell, K.I.E., Ensor, J., et al. (2019) 'Minimum sample size for developing a multivariable prediction model: Part II â€“ binary and time-to-event outcomes', Statistics in Medicine, 38(7), pp.1276â€“1296.



Riley, R.D., Ensor, J., Snell, K.I.E., et al. (2020) 'Calculating the sample size required for developing a clinical prediction model', BMJ, 368:m441.



van der Ploeg, T., Austin, P.C. & Steyerberg, E.W. (2014) 'Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints', BMC Medical Research Methodology, 14:137.



van Smeden, M., de Groot, J.A.H., Moons, K.G.M., et al. (2016) 'No rationale for 1 variable per 10 events criterion for binary logistic regression analysis', BMC Medical Research Methodology, 16:163.



Walter, S. & Tiemeier, H. (2009) 'Variable selection: current practice in epidemiological studies', European Journal of Epidemiology, 24(12), pp.733â€“736.















# Events Per Parameter (EPP) Reflection 


### Diagnostic Framework for Feature Utilisation in UK Biobank






## 1. The Fundamental Tension in Prediction Modelling


Every prediction model asks data to reveal patterns. But data has finite information content â€” it can reliably teach a limited number of "lessons" before the model begins fitting noise rather than signal.





~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚   <strong>MORE FEATURES </strong> â”€â”€â”€â”€â”€â”€â”€â–º  More potential patterns to discover          â”‚
â”‚        â”‚                                                                â”‚
â”‚        â”‚                   <strong>BUT ALSO</strong>                                     â”‚
â”‚        â–¼                                                                â”‚
â”‚   <strong>MORE PARAMETERS </strong>â”€â”€â”€â”€â”€â”€â–º  More &quot;lessons&quot; the data must teach           â”‚
â”‚        â”‚                                                                â”‚
â”‚        â”‚                   <strong>WHICH MEANS</strong>                                  â”‚
â”‚        â–¼                                                                â”‚
â”‚   <strong>HIGHER RISK</strong> â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â–º  Learning noise instead of signal             â”‚
â”‚                            (overfitting)                                â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚   \textbf{MORE FEATURES } â”€â”€â”€â”€â”€â”€â”€â–º  More potential patterns to discover          â”‚
â”‚        â”‚                                                                â”‚
â”‚        â”‚                   \textbf{BUT ALSO}                                     â”‚
â”‚        â–¼                                                                â”‚
â”‚   \textbf{MORE PARAMETERS }â”€â”€â”€â”€â”€â”€â–º  More "lessons" the data must teach           â”‚
â”‚        â”‚                                                                â”‚
â”‚        â”‚                   \textbf{WHICH MEANS}                                  â”‚
â”‚        â–¼                                                                â”‚
â”‚   \textbf{HIGHER RISK} â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â–º  Learning noise instead of signal             â”‚
â”‚                            (overfitting)                                â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
\end{Verbatim}
~~~




The methodological literature frames this as a sample size problem: 


- _how much data do we need for a given model complexity?_

But the question can be inverted, given the data available: 


- _how much model complexity could researchers support_
- _how much are they researchers actually using_





---


## 2. Why Events Determine Learning Capacity (Not Total N)


For binary outcomes, the effective sample size is determined by the number of outcome events, the less frequent category, not total participants.



### 2.1 Intuition


Consider learning to distinguish people who develop a rare disease:





~~~{=html}
<pre class="notion-ascii-diagram"><code><strong>Scenario A: Common outcome (50% prevalence, 50% have the disease)</strong>
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹ â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹                       â”‚
â”‚  â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹ â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹                       â”‚
â”‚                                                                â”‚
â”‚  N = 40    Events (â—) = 20    Non-events (â—‹) = 20              â”‚
â”‚                                                                â”‚
â”‚  <strong>Abundant examples in both groups</strong>                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

<strong>Scenario B: Rare outcome (5% prevalence, 5% have the disease)</strong>
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹                   â”‚
â”‚  â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â— â— â—‹ â—‹                   â”‚
â”‚                                                            â”‚
â”‚  N = 40    Events (â—) = 2     Non-events (â—‹) = 38          â”‚
â”‚                                                            â”‚
â”‚  <strong>Only 2 examples of the outcome to learn from </strong>             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
\textbf{Scenario A: Common outcome (50% prevalence, 50% have the disease)}
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹ â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹                       â”‚
â”‚  â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹ â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹                       â”‚
â”‚                                                                â”‚
â”‚  N = 40    Events (â—) = 20    Non-events (â—‹) = 20              â”‚
â”‚                                                                â”‚
â”‚  \textbf{Abundant examples in both groups}                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

\textbf{Scenario B: Rare outcome (5% prevalence, 5% have the disease)}
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹                   â”‚
â”‚  â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â— â— â—‹ â—‹                   â”‚
â”‚                                                            â”‚
â”‚  N = 40    Events (â—) = 2     Non-events (â—‹) = 38          â”‚
â”‚                                                            â”‚
â”‚  \textbf{Only 2 examples of the outcome to learn from }             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
\end{Verbatim}
~~~




In Scenario B, despite N=40, the learning capacity is constrained by only 2 events. With only 2 events to learn from, the model cannot reliably estimate many parameters



âˆ´ lower prevalence, have the disease, directly limits how many features can be safely included.



### 2.2 Mathematical Basis


Riley et al. (2019, 2020) formalise this: the number of events bounds the number of parameters that can be estimated with acceptable shrinkage (i.e., without coefficients being systematically too extreme).







---


## 3. The Feature-Parameter Distinction


A foundational point in prediction modelling methodology: the cost to a model is measured in parameters, not features (Riley et al., 2019; Harrell, 2015). The mapping is not 1:1. Whether this distinction is consistently made explicit in UK Biobank prediction papers is an empirical question.



### 3.1 Parameter Expansion Rules




~~~{=html}
<pre class="notion-ascii-diagram"><code><strong>FEATURE TYPE                          PARAMETERS REQUIRED</strong>
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

1.<strong>Binary (Yes/No) </strong>                    1 parameter
   e.g., Sex                          â–¶ 1 coefficient

2.<strong>Continuous (linear) </strong>                1 parameter
   e.g., Age in years                 â–¶ 1 coefficient

3.<strong>Continuous (non-linear, spline)</strong>     3â€“5 parameters typically
   e.g., Age with RCS, 4 knots        â–¶ 4 coefficients

4.<strong>Categorical (k levels)  </strong>            (k âˆ’ 1) parameters
   e.g., Smoking: Never/Former/       â–¶ 3 coefficients
         Light/Heavy (4 levels)

5.<strong>Interactions</strong>                        Multiplicative
   e.g., Age Ã— Sex                    â–¶ 1 additional parameter
   e.g., Age (spline) Ã— Sex           â–¶ 4 additional parameters

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

<strong>REFLECTIVE NOTES:</strong>

3.<strong>Why splines expand parameters:</strong>
A spline allows the effect to curve rather than stay straight. 
&quot;Knots&quot; are points where the curve can bend.

<strong>Linear (1 param): </strong>    <strong>Spline, 4 knots (3 params):</strong>
                      
Risk     â•±            Risk        â•±
 â”‚     â•±               â”‚       â•±â”€â”€
 â”‚   â•±                 â”‚    â•±â”€â”€
 â”‚ â•±                   â”‚  â•±
 â””â”€â”€â”€â”€â”€â”€ Age           â””â”€â”€â”€â”€â”€â”€ Age

Same slope             Slope changes at
everywhere             each knot

The rule: parameters = knots - 1

<strong>3 knots â†’ 2 parameters
4 knots â†’ 3 parameters
5 knots â†’ 4 parameters</strong>


5.<strong>Why interactions multiply:</strong>
An interaction asks &quot;does the effect of A change depending on B?&quot;

5.<strong>1 Age Ã— Sex (both simple):</strong>
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
One parameter for age. The interaction asks:
&quot;Is the slope different for men vs women?&quot;

â–¶ 1 extra parameter (adjust slope if male)


5.<strong>2 Age (spline) Ã— Sex:</strong>
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Three parameters for age (the curve shape). The interaction asks:
&quot;Is the entire curve shape different for men vs women?&quot;

â–¶ 3 extra parameters (adjust each bend if male)

<strong>The rule: multiply the parameters in each term.</strong>

1 (age linear) Ã— 1 (sex) = 1 interaction parameter
3 (age spline) Ã— 1 (sex) = 3 interaction parameters
3 (age spline) Ã— 3 (BMI spline) = 9 interaction parameters
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
\textbf{FEATURE TYPE                          PARAMETERS REQUIRED}
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

1.\textbf{Binary (Yes/No) }                    1 parameter
   e.g., Sex                          â–¶ 1 coefficient

2.\textbf{Continuous (linear) }                1 parameter
   e.g., Age in years                 â–¶ 1 coefficient

3.\textbf{Continuous (non-linear, spline)}     3â€“5 parameters typically
   e.g., Age with RCS, 4 knots        â–¶ 4 coefficients

4.\textbf{Categorical (k levels)  }            (k âˆ’ 1) parameters
   e.g., Smoking: Never/Former/       â–¶ 3 coefficients
         Light/Heavy (4 levels)

5.\textbf{Interactions}                        Multiplicative
   e.g., Age Ã— Sex                    â–¶ 1 additional parameter
   e.g., Age (spline) Ã— Sex           â–¶ 4 additional parameters

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

\textbf{REFLECTIVE NOTES:}

3.\textbf{Why splines expand parameters:}
A spline allows the effect to curve rather than stay straight. 
"Knots" are points where the curve can bend.

\textbf{Linear (1 param): }    \textbf{Spline, 4 knots (3 params):}
                      
Risk     â•±            Risk        â•±
 â”‚     â•±               â”‚       â•±â”€â”€
 â”‚   â•±                 â”‚    â•±â”€â”€
 â”‚ â•±                   â”‚  â•±
 â””â”€â”€â”€â”€â”€â”€ Age           â””â”€â”€â”€â”€â”€â”€ Age

Same slope             Slope changes at
everywhere             each knot

The rule: parameters = knots - 1

\textbf{3 knots â†’ 2 parameters
4 knots â†’ 3 parameters
5 knots â†’ 4 parameters}


5.\textbf{Why interactions multiply:}
An interaction asks "does the effect of A change depending on B?"

5.\textbf{1 Age Ã— Sex (both simple):}
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
One parameter for age. The interaction asks:
"Is the slope different for men vs women?"

â–¶ 1 extra parameter (adjust slope if male)


5.\textbf{2 Age (spline) Ã— Sex:}
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Three parameters for age (the curve shape). The interaction asks:
"Is the entire curve shape different for men vs women?"

â–¶ 3 extra parameters (adjust each bend if male)

\textbf{The rule: multiply the parameters in each term.}

1 (age linear) Ã— 1 (sex) = 1 interaction parameter
3 (age spline) Ã— 1 (sex) = 3 interaction parameters
3 (age spline) Ã— 3 (BMI spline) = 9 interaction parameters

\end{Verbatim}
~~~








### 3.2 Worked Example: A "6-Feature" Model


Consider a typical UK Biobank core predictor set:





~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ <strong>                 FEATURE-TO-PARAMETER EXPANSION   </strong>                  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                     â”‚
â”‚  <strong>Feature              Modelling choice         Parameters  </strong>         â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                     â”‚
â”‚<strong>  SIMPLE SPECIFICATION:  </strong>                                            â”‚
â”‚  Age (21022)          Linear                   1                    â”‚
â”‚  Sex (31)             Binary                   1                    â”‚
â”‚  BMI (21001)          Linear                   1                    â”‚
â”‚  Smoking (20116)      4 categories             3                    â”‚
â”‚  HbA1c (30750)        Linear                   1                    â”‚
â”‚  Townsend (189)       Linear                   1                    â”‚
â”‚                                                â”€â”€â”€â”€â”€                â”‚
â”‚                       <strong>Subtotal:                8 parameters </strong>        â”‚
â”‚                                                                     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                     â”‚
â”‚  <strong>REALISTIC SPECIFICATION (with non-linear terms): </strong>                  â”‚
â”‚  Age (21022)          RCS, 4 df                4                    â”‚
â”‚  Sex (31)             Binary                   1                    â”‚
â”‚  BMI (21001)          RCS, 4 df                4                    â”‚
â”‚  Smoking (20116)      4 categories             3                    â”‚
â”‚  HbA1c (30750)        RCS, 4 df                4                    â”‚
â”‚  Townsend (189)       Linear                   1                    â”‚
â”‚                                                â”€â”€â”€â”€â”€                â”‚
â”‚                       <strong>Subtotal:                17 parameters   </strong>     â”‚
â”‚                                                                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

<strong>Observation:</strong> 
&quot;6 features&quot; translates to 8â€“17 parameters depending on modelling 
decisions. Whether papers typically report this expansion is an 
empirical question.</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ \textbf{                 FEATURE-TO-PARAMETER EXPANSION   }                  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                     â”‚
â”‚  \textbf{Feature              Modelling choice         Parameters  }         â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                     â”‚
â”‚\textbf{  SIMPLE SPECIFICATION:  }                                            â”‚
â”‚  Age (21022)          Linear                   1                    â”‚
â”‚  Sex (31)             Binary                   1                    â”‚
â”‚  BMI (21001)          Linear                   1                    â”‚
â”‚  Smoking (20116)      4 categories             3                    â”‚
â”‚  HbA1c (30750)        Linear                   1                    â”‚
â”‚  Townsend (189)       Linear                   1                    â”‚
â”‚                                                â”€â”€â”€â”€â”€                â”‚
â”‚                       \textbf{Subtotal:                8 parameters }        â”‚
â”‚                                                                     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                     â”‚
â”‚  \textbf{REALISTIC SPECIFICATION (with non-linear terms): }                  â”‚
â”‚  Age (21022)          RCS, 4 df                4                    â”‚
â”‚  Sex (31)             Binary                   1                    â”‚
â”‚  BMI (21001)          RCS, 4 df                4                    â”‚
â”‚  Smoking (20116)      4 categories             3                    â”‚
â”‚  HbA1c (30750)        RCS, 4 df                4                    â”‚
â”‚  Townsend (189)       Linear                   1                    â”‚
â”‚                                                â”€â”€â”€â”€â”€                â”‚
â”‚                       \textbf{Subtotal:                17 parameters   }     â”‚
â”‚                                                                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

\textbf{Observation:} 
"6 features" translates to 8â€“17 parameters depending on modelling 
decisions. Whether papers typically report this expansion is an 
empirical question.
\end{Verbatim}
~~~








---


## 4. Defining Events Per Parameter (EPP)


### 4.1 The Core Ratio




~~~{=html}
<pre class="notion-ascii-diagram"><code>                         <strong>Number of outcome events</strong>
           <strong>EPP </strong>   =     â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
                         <strong>Number of parameters</strong>
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
                         \textbf{Number of outcome events}
           \textbf{EPP }   =     â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
                         \textbf{Number of parameters}

\end{Verbatim}
~~~




### 4.2 Historical Thresholds and Their Limitations


The "10 EPV" rule (events per variable) emerged from 1990s simulation studies (Peduzzi et al., 1996). 



It was never intended as a universal standard.





~~~{=html}
<pre class="notion-ascii-diagram"><code>EPP INTERPRETATION (approximate, context-dependent)
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

EPP &lt; 10        High overfitting risk
                Coefficient estimates unstable
                Performance degrades on new data
                âš ï¸  Many published models operate here

EPP 10â€“20       Traditional threshold
                van Smeden et al. (2016): not reliable as
                universal criterion

EPP 20â€“50       Generally adequate for logistic regression
                Riley et al. (2019): target shrinkage â‰¥ 0.9

EPP &gt; 50        Comfortable margin
                Still depends on signal strength (RÂ²) and prevalence

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Key point: EPP is necessary but not sufficient. The appropriate
           threshold depends on outcome prevalence, expected RÂ²,
           and tolerable shrinkage.
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
EPP INTERPRETATION (approximate, context-dependent)
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

EPP < 10        High overfitting risk
                Coefficient estimates unstable
                Performance degrades on new data
                âš ï¸  Many published models operate here

EPP 10â€“20       Traditional threshold
                van Smeden et al. (2016): not reliable as
                universal criterion

EPP 20â€“50       Generally adequate for logistic regression
                Riley et al. (2019): target shrinkage â‰¥ 0.9

EPP > 50        Comfortable margin
                Still depends on signal strength (RÂ²) and prevalence

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Key point: EPP is necessary but not sufficient. The appropriate
           threshold depends on outcome prevalence, expected RÂ²,
           and tolerable shrinkage.

\end{Verbatim}
~~~




### 4.3 The Riley et al. (2020) Refinement


Modern sample size calculations incorporate:


1. **Outcome prevalence** â€” determines maximum achievable RÂ²
2. **Anticipated model performance (RÂ²)** â€” weaker signals require more events
3. **Target shrinkage factor** â€” typically â‰¥ 0.9 (â‰¤10% overfitting)
4. **Precision requirements** â€” desired confidence interval width

This yields context-specific sample size requirements rather than fixed EPP thresholds.



---


## 5. UK Biobank: Applying the Framework


### 5.1 Baseline Numbers




~~~{=html}
<pre class="notion-ascii-diagram"><code>UK BIOBANK SCALE
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Total participants:          ~500,000
Available fields/features:   ~10,000+ (direct measures, derived, etc.)

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
UK BIOBANK SCALE
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Total participants:          ~500,000
Available fields/features:   ~10,000+ (direct measures, derived, etc.)

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




### 5.2 EPP-Supportable Complexity by Prevalence




~~~{=html}
<pre class="notion-ascii-diagram"><code>MAXIMUM DEFENSIBLE PARAMETERS AT DIFFERENT PREVALENCES
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

                                           Max parameters at:
Prevalence    Events (N=500k)       EPP=20         EPP=50
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
10.0%         50,000                2,500          1,000
5.0%          25,000                1,250          500
1.0%          5,000                 250            100
0.5%          2,500                 125            50
0.1%          500                   25             10
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

These are UPPER BOUNDS on model complexity given statistical constraints

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
MAXIMUM DEFENSIBLE PARAMETERS AT DIFFERENT PREVALENCES
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

                                           Max parameters at:
Prevalence    Events (N=500k)       EPP=20         EPP=50
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
10.0%         50,000                2,500          1,000
5.0%          25,000                1,250          500
1.0%          5,000                 250            100
0.5%          2,500                 125            50
0.1%          500                   25             10
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

These are UPPER BOUNDS on model complexity given statistical constraints

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




ARE YOU USING TOO FEW OR TOO MANY PARAMETERS?
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
Safe range                         If using ~50 parameters:
Prevalence       Events            Min              Max



(% with outcome) (N=500k)     (EPP=50, conservative)  (EPP=20, relaxed)      Status    Interpretation
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
10.0%            50,000            1,000              2,500                   ğŸ”´        Wasting data
5.0%             25,000              500              1,250                   ğŸ”´        Wasting data
2.0%             10,000              200                500                   ğŸ”´        Wasting data
1.0%              5,000              100                250                   ğŸ”´        Wasting data
0.5%              2,500               50                125                   ğŸŸ¢        Appropriate
0.2%              1,000               20                 50                   ğŸŸ¢        At lower bound
0.1%                500               10                 25                   ğŸ”´        Overfitting risk
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
ğŸ”´ Outside safe range    ğŸŸ¢ Within safe range



A fixed ~50-parameter approach only fits outcomes with 0.2â€“0.5% prevalence
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•











### 5.3 Visual Representation




~~~{=html}
<pre class="notion-ascii-diagram"><code>              PARAMETER BUDGET BY OUTCOME PREVALENCE
              (UK Biobank, N â‰ˆ 500,000, EPP = 20)

Parameters
    â”‚
2500â”¤ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â† 10% prevalence
    â”‚                                                  (50,000 events)
2000â”¤
    â”‚
1500â”¤
    â”‚
1250â”¤ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ              â† 5% prevalence
    â”‚                                                  (25,000 events)
1000â”¤
    â”‚
 750â”¤
    â”‚
 500â”¤
    â”‚
 250â”¤ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ                                        â† 1% prevalence
    â”‚                                                  (5,000 events)
 125â”¤ â–ˆâ–ˆâ–ˆâ–ˆ                                           â† 0.5% prevalence
    â”‚
  25â”¤ â–ˆ                                              â† 0.1% prevalence
    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
              PARAMETER BUDGET BY OUTCOME PREVALENCE
              (UK Biobank, N â‰ˆ 500,000, EPP = 20)

Parameters
    â”‚
2500â”¤ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â† 10% prevalence
    â”‚                                                  (50,000 events)
2000â”¤
    â”‚
1500â”¤
    â”‚
1250â”¤ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ              â† 5% prevalence
    â”‚                                                  (25,000 events)
1000â”¤
    â”‚
 750â”¤
    â”‚
 500â”¤
    â”‚
 250â”¤ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ                                        â† 1% prevalence
    â”‚                                                  (5,000 events)
 125â”¤ â–ˆâ–ˆâ–ˆâ–ˆ                                           â† 0.5% prevalence
    â”‚
  25â”¤ â–ˆ                                              â† 0.1% prevalence
    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

\end{Verbatim}
~~~




---


## 6. Inverting the Question: EPP as Diagnostic Tool


### 6.1 The Standard Framing


EPP is conventionally presented as a constraint:


> "Do I have enough events for the features I want to include?"

This protects individual studies from overfitting.



### 6.2 The Investigative Framing


But EPP can equally serve as a diagnostic:


> "Given the events available, why are researchers using so few features?"

This characterises field-wide patterns of feature selection.



### 6.3 The Utilisation Ratio


If we can measure both quantities, we can compute:





~~~{=html}
<pre class="notion-ascii-diagram"><code>                          Parameters actually used
  Utilisation ratio  =   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
                          Parameters supportable (EPP)
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
                          Parameters actually used
  Utilisation ratio  =   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
                          Parameters supportable (EPP)

\end{Verbatim}
~~~




---


## 7. Hypothetical Scenarios


### 7.1 Utilisation Near Capacity




~~~{=html}
<pre class="notion-ascii-diagram"><code>SCENARIO A: Researchers approaching statistical limits
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Study parameters:
  - Outcome prevalence: 5%
  - Events: 25,000
  - EPP threshold: 20
  - Supportable parameters: 1,250

Observed:
  - Parameters used: 1,100 (â‰ˆ 200+ features with expansions)

Utilisation ratio: 1,100 / 1,250 = 88%

Interpretation:
  Feature selection appears constrained by EPP.
  Researchers are exploring near the statistical limit.
  Underutilisation is NOT occurring.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
SCENARIO A: Researchers approaching statistical limits
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Study parameters:
  - Outcome prevalence: 5%
  - Events: 25,000
  - EPP threshold: 20
  - Supportable parameters: 1,250

Observed:
  - Parameters used: 1,100 (â‰ˆ 200+ features with expansions)

Utilisation ratio: 1,100 / 1,250 = 88%

Interpretation:
  Feature selection appears constrained by EPP.
  Researchers are exploring near the statistical limit.
  Underutilisation is NOT occurring.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




### 7.2 Utilisation Far Below Capacity




~~~{=html}
<pre class="notion-ascii-diagram"><code>SCENARIO B: Researchers far below statistical limits
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Study parameters:
  - Outcome prevalence: 5%
  - Events: 25,000
  - EPP threshold: 20
  - Supportable parameters: 1,250

Observed:
  - Parameters used: 50 (â‰ˆ 20â€“30 features)

Utilisation ratio: 50 / 1,250 = 4%

Interpretation:
  Researchers are using only 4% of their statistical budget.
  The constraint is NOT EPP.
  Something else is limiting feature exploration.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
SCENARIO B: Researchers far below statistical limits
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Study parameters:
  - Outcome prevalence: 5%
  - Events: 25,000
  - EPP threshold: 20
  - Supportable parameters: 1,250

Observed:
  - Parameters used: 50 (â‰ˆ 20â€“30 features)

Utilisation ratio: 50 / 1,250 = 4%

Interpretation:
  Researchers are using only 4% of their statistical budget.
  The constraint is NOT EPP.
  Something else is limiting feature exploration.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




---


## 8. Possible Interpretations of Low Utilisation (If Observed)


The following hypotheses would become relevant if systematic analysis revealed UK Biobank studies consistently operate far below EPP capacity. These are interpretive frameworks, not established findings.



### 8.1 Possible Interpretation: Convergence on a "Core" Feature Set




~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚   10,000+ available UK Biobank features                                 â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                         â–²                                               â”‚
â”‚                         â”‚                                               â”‚
â”‚                Hypothetical &quot;core&quot; ~50 features                         â”‚
â”‚                (if such convergence exists)                             â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

If such a pattern were found empirically, possible explanations might include:

  â€¢ These features are genuinely most predictive for most outcomes
  â€¢ These features are most accessible (complete, easy to process)
  â€¢ Citation/replication practices reinforce &quot;established&quot; predictors
  â€¢ Methods sections are adapted from prior work
  â€¢ Reviewer expectations favour familiar features

Each explanation would require separate investigation.
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚   10,000+ available UK Biobank features                                 â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                         â–²                                               â”‚
â”‚                         â”‚                                               â”‚
â”‚                Hypothetical "core" ~50 features                         â”‚
â”‚                (if such convergence exists)                             â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

If such a pattern were found empirically, possible explanations might include:

  â€¢ These features are genuinely most predictive for most outcomes
  â€¢ These features are most accessible (complete, easy to process)
  â€¢ Citation/replication practices reinforce "established" predictors
  â€¢ Methods sections are adapted from prior work
  â€¢ Reviewer expectations favour familiar features

Each explanation would require separate investigation.

\end{Verbatim}
~~~




### 8.2 Possible Interpretation: Outcome-Feature Mismatch




~~~{=html}
<pre class="notion-ascii-diagram"><code>EXPECTED PATTERN (if feature selection is outcome-driven):
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Different outcomes should draw on different feature pools

Cardiovascular outcomes:              Neurological outcomes:
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”          â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Lipids                  â”‚          â”‚ Cognitive tests         â”‚
â”‚ Blood pressure          â”‚          â”‚ Brain imaging           â”‚
â”‚ ECG measures            â”‚          â”‚ Reaction time           â”‚
â”‚ Exercise capacity       â”‚          â”‚ Mood/sleep              â”‚
â”‚ Smoking, diet           â”‚          â”‚ Education               â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜          â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
        Distinct feature pools with limited overlap


ALTERNATIVE PATTERN (if a core exists):
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Different outcomes draw on same feature pool

Cardiovascular outcomes:              Neurological outcomes:
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”          â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Age, Sex, BMI           â”‚          â”‚ Age, Sex, BMI           â”‚
â”‚ Smoking status          â”‚          â”‚ Smoking status          â”‚
â”‚ Townsend index          â”‚          â”‚ Townsend index          â”‚
â”‚ Blood pressure          â”‚          â”‚ Blood pressure          â”‚
â”‚ ...                     â”‚          â”‚ ...                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜          â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
        Near-identical despite distinct clinical domains

If so: Are outcome-specific features being systematically ignored?

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
EXPECTED PATTERN (if feature selection is outcome-driven):
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Different outcomes should draw on different feature pools

Cardiovascular outcomes:              Neurological outcomes:
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”          â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Lipids                  â”‚          â”‚ Cognitive tests         â”‚
â”‚ Blood pressure          â”‚          â”‚ Brain imaging           â”‚
â”‚ ECG measures            â”‚          â”‚ Reaction time           â”‚
â”‚ Exercise capacity       â”‚          â”‚ Mood/sleep              â”‚
â”‚ Smoking, diet           â”‚          â”‚ Education               â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜          â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
        Distinct feature pools with limited overlap


ALTERNATIVE PATTERN (if a core exists):
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Different outcomes draw on same feature pool

Cardiovascular outcomes:              Neurological outcomes:
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”          â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Age, Sex, BMI           â”‚          â”‚ Age, Sex, BMI           â”‚
â”‚ Smoking status          â”‚          â”‚ Smoking status          â”‚
â”‚ Townsend index          â”‚          â”‚ Townsend index          â”‚
â”‚ Blood pressure          â”‚          â”‚ Blood pressure          â”‚
â”‚ ...                     â”‚          â”‚ ...                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜          â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
        Near-identical despite distinct clinical domains

If so: Are outcome-specific features being systematically ignored?

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




### 8.3 Possible Interpretation: Feature Selection Misalignment


EPP constrains how many parameters can be estimated. It says nothing about whether the right parameters are being estimated.





~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  Two models, both statistically adequate (EPP = 50)                     â”‚
â”‚                                                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚ MODEL A: Features with genuine predictive/causal relationships  â”‚   â”‚
â”‚  â”‚                                                                 â”‚   â”‚
â”‚  â”‚   â†’ Good discrimination (AUC ~ 0.80)                            â”‚   â”‚
â”‚  â”‚   â†’ Stable calibration across populations                       â”‚   â”‚
â”‚  â”‚   â†’ Transportable to external cohorts                           â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚ MODEL B: Features that are proxies, confounded, or local        â”‚   â”‚
â”‚  â”‚                                                                 â”‚   â”‚
â”‚  â”‚   â†’ Modest discrimination (AUC ~ 0.65)                          â”‚   â”‚
â”‚  â”‚   â†’ Calibration degrades on external validation                 â”‚   â”‚
â”‚  â”‚   â†’ Poor transportability                                       â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                                         â”‚
â”‚  EPP CANNOT DISTINGUISH BETWEEN A AND B                                 â”‚
â”‚                                                                         â”‚
â”‚  If researchers consistently select from a narrow pool, they may:       â”‚
â”‚    â€¢ Miss features that would improve prediction                        â”‚
â”‚    â€¢ Include features by convention rather than evidence                â”‚
â”‚    â€¢ Fail to consider disease-specific biology                          â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  Two models, both statistically adequate (EPP = 50)                     â”‚
â”‚                                                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚ MODEL A: Features with genuine predictive/causal relationships  â”‚   â”‚
â”‚  â”‚                                                                 â”‚   â”‚
â”‚  â”‚   â†’ Good discrimination (AUC ~ 0.80)                            â”‚   â”‚
â”‚  â”‚   â†’ Stable calibration across populations                       â”‚   â”‚
â”‚  â”‚   â†’ Transportable to external cohorts                           â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚ MODEL B: Features that are proxies, confounded, or local        â”‚   â”‚
â”‚  â”‚                                                                 â”‚   â”‚
â”‚  â”‚   â†’ Modest discrimination (AUC ~ 0.65)                          â”‚   â”‚
â”‚  â”‚   â†’ Calibration degrades on external validation                 â”‚   â”‚
â”‚  â”‚   â†’ Poor transportability                                       â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                                         â”‚
â”‚  EPP CANNOT DISTINGUISH BETWEEN A AND B                                 â”‚
â”‚                                                                         â”‚
â”‚  If researchers consistently select from a narrow pool, they may:       â”‚
â”‚    â€¢ Miss features that would improve prediction                        â”‚
â”‚    â€¢ Include features by convention rather than evidence                â”‚
â”‚    â€¢ Fail to consider disease-specific biology                          â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

\end{Verbatim}
~~~




---


## 9. Medical Ontologies as Independent Benchmark


Medical ontologies (MONDO, HPO, EFO, ICD-10, SNOMED-CT) encode structured domain knowledge:


- Which biological processes relate to which diseases
- Which measurements reflect which physiological states
- Which features _should_ be relevant based on clinical/biological reasoning

This provides an independent reference point, separate from what papers actually use.



### 9.1 Example: Type 2 Diabetes




~~~{=html}
<pre class="notion-ascii-diagram"><code>ONTOLOGY-DERIVED EXPECTED FEATURES FOR T2D (MONDO:0005148)
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Domain knowledge suggests these feature categories are relevant:

â”œâ”€â”€ Metabolic markers
â”‚   â”œâ”€â”€ HbA1c
â”‚   â”œâ”€â”€ Fasting glucose
â”‚   â”œâ”€â”€ Insulin levels
â”‚   â”œâ”€â”€ C-peptide
â”‚   â””â”€â”€ Lipid panel (TG, HDL, LDL)
â”‚
â”œâ”€â”€ Anthropometric
â”‚   â”œâ”€â”€ BMI
â”‚   â”œâ”€â”€ Waist circumference
â”‚   â”œâ”€â”€ Waist-hip ratio
â”‚   â””â”€â”€ Body fat percentage
â”‚
â”œâ”€â”€ Genetic/familial
â”‚   â”œâ”€â”€ TCF7L2 variants
â”‚   â”œâ”€â”€ Polygenic risk scores
â”‚   â””â”€â”€ Family history
â”‚
â”œâ”€â”€ Lifestyle
â”‚   â”œâ”€â”€ Physical activity measures
â”‚   â”œâ”€â”€ Diet composition
â”‚   â”œâ”€â”€ Sleep duration/quality
â”‚   â””â”€â”€ Alcohol consumption
â”‚
â”œâ”€â”€ Comorbidity indicators
â”‚   â”œâ”€â”€ Blood pressure
â”‚   â”œâ”€â”€ Kidney function (eGFR, creatinine)
â”‚   â”œâ”€â”€ Liver function (ALT, GGT)
â”‚   â””â”€â”€ Inflammatory markers (CRP)
â”‚
â””â”€â”€ Sociodemographic
    â”œâ”€â”€ Age
    â”œâ”€â”€ Sex
    â”œâ”€â”€ Ethnicity
    â””â”€â”€ Deprivation indices

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Empirical question: What features do T2D prediction papers actually use?

Gap between ontology-suggested and actually-used = potential underutilisation

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
ONTOLOGY-DERIVED EXPECTED FEATURES FOR T2D (MONDO:0005148)
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Domain knowledge suggests these feature categories are relevant:

â”œâ”€â”€ Metabolic markers
â”‚   â”œâ”€â”€ HbA1c
â”‚   â”œâ”€â”€ Fasting glucose
â”‚   â”œâ”€â”€ Insulin levels
â”‚   â”œâ”€â”€ C-peptide
â”‚   â””â”€â”€ Lipid panel (TG, HDL, LDL)
â”‚
â”œâ”€â”€ Anthropometric
â”‚   â”œâ”€â”€ BMI
â”‚   â”œâ”€â”€ Waist circumference
â”‚   â”œâ”€â”€ Waist-hip ratio
â”‚   â””â”€â”€ Body fat percentage
â”‚
â”œâ”€â”€ Genetic/familial
â”‚   â”œâ”€â”€ TCF7L2 variants
â”‚   â”œâ”€â”€ Polygenic risk scores
â”‚   â””â”€â”€ Family history
â”‚
â”œâ”€â”€ Lifestyle
â”‚   â”œâ”€â”€ Physical activity measures
â”‚   â”œâ”€â”€ Diet composition
â”‚   â”œâ”€â”€ Sleep duration/quality
â”‚   â””â”€â”€ Alcohol consumption
â”‚
â”œâ”€â”€ Comorbidity indicators
â”‚   â”œâ”€â”€ Blood pressure
â”‚   â”œâ”€â”€ Kidney function (eGFR, creatinine)
â”‚   â”œâ”€â”€ Liver function (ALT, GGT)
â”‚   â””â”€â”€ Inflammatory markers (CRP)
â”‚
â””â”€â”€ Sociodemographic
    â”œâ”€â”€ Age
    â”œâ”€â”€ Sex
    â”œâ”€â”€ Ethnicity
    â””â”€â”€ Deprivation indices

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Empirical question: What features do T2D prediction papers actually use?

Gap between ontology-suggested and actually-used = potential underutilisation

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




---


## 10. A Testable Research Framework


The EPP framework enables a specific, quantitative research programme:



### 10.1 Three Quantities to Compare




~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  For each UK Biobank prediction study, measure:                         â”‚
â”‚                                                                         â”‚
â”‚    (a) STATISTICAL CAPACITY                                             â”‚
â”‚        Parameters supportable given event count and EPP threshold       â”‚
â”‚        â†’ Calculated from: events / EPP_threshold                        â”‚
â”‚                                                                         â”‚
â”‚    (b) ACTUAL UTILISATION                                               â”‚
â”‚        Parameters actually used in the published model                  â”‚
â”‚        â†’ Extracted from: methods sections, supplementary materials      â”‚
â”‚                                                                         â”‚
â”‚    (c) DOMAIN EXPECTATION                                               â”‚
â”‚        Features suggested by medical ontologies for that outcome        â”‚
â”‚        â†’ Derived from: MONDO, HPO, EFO mappings to UKB fields           â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  For each UK Biobank prediction study, measure:                         â”‚
â”‚                                                                         â”‚
â”‚    (a) STATISTICAL CAPACITY                                             â”‚
â”‚        Parameters supportable given event count and EPP threshold       â”‚
â”‚        â†’ Calculated from: events / EPP_threshold                        â”‚
â”‚                                                                         â”‚
â”‚    (b) ACTUAL UTILISATION                                               â”‚
â”‚        Parameters actually used in the published model                  â”‚
â”‚        â†’ Extracted from: methods sections, supplementary materials      â”‚
â”‚                                                                         â”‚
â”‚    (c) DOMAIN EXPECTATION                                               â”‚
â”‚        Features suggested by medical ontologies for that outcome        â”‚
â”‚        â†’ Derived from: MONDO, HPO, EFO mappings to UKB fields           â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

\end{Verbatim}
~~~




### 10.2 Visual Comparison




~~~{=html}
<pre class="notion-ascii-diagram"><code>         â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
         â”‚                                                      â”‚
         â”‚    (a)              (c)              (b)              â”‚
         â”‚   â”Œâ”€â”€â”€â”           â”Œâ”€â”€â”€â”            â”Œâ”€â”€â”€â”             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â””â”€â”€â”€â”˜           â””â”€â”€â”€â”˜            â””â”€â”€â”€â”˜             â”‚
         â”‚  Statistical      Ontology-        Actually          â”‚
         â”‚  capacity         suggested        used              â”‚
         â”‚                                                      â”‚
         â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
         â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
         â”‚                                                      â”‚
         â”‚    (a)              (c)              (b)              â”‚
         â”‚   â”Œâ”€â”€â”€â”           â”Œâ”€â”€â”€â”            â”Œâ”€â”€â”€â”             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â””â”€â”€â”€â”˜           â””â”€â”€â”€â”˜            â””â”€â”€â”€â”˜             â”‚
         â”‚  Statistical      Ontology-        Actually          â”‚
         â”‚  capacity         suggested        used              â”‚
         â”‚                                                      â”‚
         â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

\end{Verbatim}
~~~




### 10.3 Interpretation Matrix




~~~{=html}
<pre class="notion-ascii-diagram"><code>PATTERN                              INTERPRETATION
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

(b) â‰ˆ (a)                            Researchers operating at statistical
                                     limits. No evidence of underutilisation.

(b) &lt;&lt; (a) and (b) &lt;&lt; (c)            Systematic underutilisation.
                                     Statistical capacity is unused.
                                     Domain-relevant features ignored.
                                     â†’ STRONGEST EVIDENCE FOR PROBLEM

(b) &lt;&lt; (a) but (b) â‰ˆ (c)             Conservative but domain-appropriate.
                                     Using fewer features than possible,
                                     but aligned with domain knowledge.

(b) â‰ˆ (a) but (b) â‰  (c)              EPP-constrained but potentially
                                     mis-specified. Operating at limits
                                     but feature choice may not match
                                     domain expectations.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
PATTERN                              INTERPRETATION
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

(b) â‰ˆ (a)                            Researchers operating at statistical
                                     limits. No evidence of underutilisation.

(b) << (a) and (b) << (c)            Systematic underutilisation.
                                     Statistical capacity is unused.
                                     Domain-relevant features ignored.
                                     â†’ STRONGEST EVIDENCE FOR PROBLEM

(b) << (a) but (b) â‰ˆ (c)             Conservative but domain-appropriate.
                                     Using fewer features than possible,
                                     but aligned with domain knowledge.

(b) â‰ˆ (a) but (b) â‰  (c)              EPP-constrained but potentially
                                     mis-specified. Operating at limits
                                     but feature choice may not match
                                     domain expectations.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




---


## 11. Conditional Implications


### 11.1 What Finding a "Core" Would Mean (If Found)


The following implications are conditional on empirical findings:



If analysis were to reveal:


- A small set of features (~50) accounts for majority of feature usage
- This set is stable across diverse outcomes (cardiovascular, neurological, etc.)
- Studies operate far below EPP capacity

Then this would suggest:


- Feature selection is not EPP-constrained
- Convergence on similar features occurs despite statistical capacity for divergence
- The pattern may reflect methodological, practical, or sociological factors rather than outcome-specific reasoning

Whether such a pattern exists is an empirical question.



### 11.2 What This Framework Can and Cannot Address




~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  This framework can potentially show:                                   â”‚
â”‚    â€¢ Gap between EPP capacity and actual utilisation                    â”‚
â”‚    â€¢ Whether feature usage varies by outcome type                       â”‚
â”‚    â€¢ Degree of convergence on common features (if any)                  â”‚
â”‚                                                                         â”‚
â”‚  This framework cannot show:                                            â”‚
â”‚    â€¢ That unused features would improve prediction                      â”‚
â”‚    â€¢ That commonly used features are suboptimal                         â”‚
â”‚    â€¢ Causal relationships between features and outcomes                 â”‚
â”‚    â€¢ Whether current practice is &quot;wrong&quot;                                â”‚
â”‚                                                                         â”‚
â”‚  The framework is DIAGNOSTIC and DESCRIPTIVE                            â”‚
â”‚  It characterises patterns; it does not prescribe solutions             â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  This framework can potentially show:                                   â”‚
â”‚    â€¢ Gap between EPP capacity and actual utilisation                    â”‚
â”‚    â€¢ Whether feature usage varies by outcome type                       â”‚
â”‚    â€¢ Degree of convergence on common features (if any)                  â”‚
â”‚                                                                         â”‚
â”‚  This framework cannot show:                                            â”‚
â”‚    â€¢ That unused features would improve prediction                      â”‚
â”‚    â€¢ That commonly used features are suboptimal                         â”‚
â”‚    â€¢ Causal relationships between features and outcomes                 â”‚
â”‚    â€¢ Whether current practice is "wrong"                                â”‚
â”‚                                                                         â”‚
â”‚  The framework is DIAGNOSTIC and DESCRIPTIVE                            â”‚
â”‚  It characterises patterns; it does not prescribe solutions             â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

\end{Verbatim}
~~~




---


## 12. Summary: What EPP Reveals If a Core Feature Set Exists


The central insight emerges when we combine EPP with the possibility of a core feature set:





~~~{=html}
<pre class="notion-ascii-diagram"><code>â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

THE KEY REFRAMING
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

IF UK Biobank prediction studies converge on ~50 core features
regardless of outcome...

THEN EPP is NOT the constraint.

A study with 25,000 events (5% prevalence) could support 1,250+
parameters at EPP=20. That&#39;s capacity for hundreds of features.

Yet if researchers consistently use ~50 features across diverse
outcomes, they&#39;re operating at ~4% of statistical capacity.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

WHAT THIS WOULD MEAN
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

The problem is not:
  &quot;We can&#39;t use more features because of sample size constraints&quot;

The problem (if a core exists) may be:
  &quot;We use the SAME features regardless of how many we COULD use&quot;

This is a fundamentally different issue:
  â€¢ Not a statistical limitation
  â€¢ Not an EPP constraint
  â€¢ Potentially a behavioural/methodological/sociological pattern

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

WHAT EPP TELLS US IN THIS SCENARIO
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

EPP becomes the counterfactual that exposes the pattern:

  &quot;You had statistical budget for 1,250 parameters.
   You used 50.
   The same 50 as studies predicting entirely different outcomes.

   EPP wasn&#39;t your constraint. What was?&quot;

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

THE KEY REFRAMING
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

IF UK Biobank prediction studies converge on ~50 core features
regardless of outcome...

THEN EPP is NOT the constraint.

A study with 25,000 events (5% prevalence) could support 1,250+
parameters at EPP=20. That's capacity for hundreds of features.

Yet if researchers consistently use ~50 features across diverse
outcomes, they're operating at ~4% of statistical capacity.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

WHAT THIS WOULD MEAN
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

The problem is not:
  "We can't use more features because of sample size constraints"

The problem (if a core exists) may be:
  "We use the SAME features regardless of how many we COULD use"

This is a fundamentally different issue:
  â€¢ Not a statistical limitation
  â€¢ Not an EPP constraint
  â€¢ Potentially a behavioural/methodological/sociological pattern

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

WHAT EPP TELLS US IN THIS SCENARIO
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

EPP becomes the counterfactual that exposes the pattern:

  "You had statistical budget for 1,250 parameters.
   You used 50.
   The same 50 as studies predicting entirely different outcomes.

   EPP wasn't your constraint. What was?"

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




### 12.1 The Research Question, Restated




~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  This is not about whether researchers use TOO MANY features.           â”‚
â”‚  EPP already addresses that question.                                   â”‚
â”‚                                                                         â”‚
â”‚  This is about whether researchers use THE SAME features                â”‚
â”‚  across outcomes where:                                                 â”‚
â”‚                                                                         â”‚
â”‚    (a) EPP would permit far more exploration                            â”‚
â”‚    (b) Domain knowledge suggests different features are relevant        â”‚
â”‚    (c) The convergence cannot be explained by statistical constraints   â”‚
â”‚                                                                         â”‚
â”‚  If such a pattern exists, it suggests feature selection in UK Biobank  â”‚
â”‚  research may be driven by factors other than outcome-specific          â”‚
â”‚  statistical or clinical reasoning.                                     â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  This is not about whether researchers use TOO MANY features.           â”‚
â”‚  EPP already addresses that question.                                   â”‚
â”‚                                                                         â”‚
â”‚  This is about whether researchers use THE SAME features                â”‚
â”‚  across outcomes where:                                                 â”‚
â”‚                                                                         â”‚
â”‚    (a) EPP would permit far more exploration                            â”‚
â”‚    (b) Domain knowledge suggests different features are relevant        â”‚
â”‚    (c) The convergence cannot be explained by statistical constraints   â”‚
â”‚                                                                         â”‚
â”‚  If such a pattern exists, it suggests feature selection in UK Biobank  â”‚
â”‚  research may be driven by factors other than outcome-specific          â”‚
â”‚  statistical or clinical reasoning.                                     â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

\end{Verbatim}
~~~




### 12.2 Cautionary Notes


These notes represent a conceptual framework, not empirical findings. The claims above are conditional:


- **IF** a core feature set exists (empirical question requiring systematic review)
- **IF** utilisation is consistently low relative to EPP capacity (requires calculation across studies)
- **IF** the same features appear across diverse outcomes (requires cross-domain comparison)

Each conditional requires evidence. The framework provides the logic for interpreting such evidence if found.



---


## References


Collins, G.S., Moons, K.G.M., Dhiman, P., et al. (2024) 'TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods', BMJ, 385:e078378.



Martin, G.P., Riley, R.D., Ensor, J., & Grant, S.W. (2025) 'Statistical primer: sample size considerations for developing and validating clinical prediction models', European Journal of Cardio-Thoracic Surgery, 67(5):ezaf142.



Moons, K.G.M., Damen, J.A.A., Kaul, T., et al. (2025) 'PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods', BMJ, 388:e082505.



Peduzzi, P., Concato, J., Kemper, E., Holford, T.R. & Feinstein, A.R. (1996) 'A simulation study of the number of events per variable in logistic regression analysis', Journal of Clinical Epidemiology, 49(12), pp.1373â€“1379.



Riley, R.D., Snell, K.I.E., Ensor, J., et al. (2019) 'Minimum sample size for developing a multivariable prediction model: Part II â€“ binary and time-to-event outcomes', Statistics in Medicine, 38(7), pp.1276â€“1296.



Riley, R.D., Ensor, J., Snell, K.I.E., et al. (2020) 'Calculating the sample size required for developing a clinical prediction model', BMJ, 368:m441.



van der Ploeg, T., Austin, P.C. & Steyerberg, E.W. (2014) 'Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints', BMC Medical Research Methodology, 14:137.



van Smeden, M., de Groot, J.A.H., Moons, K.G.M., et al. (2016) 'No rationale for 1 variable per 10 events criterion for binary logistic regression analysis', BMC Medical Research Methodology, 16:163.



---


Last updated: January 2026











# Events Per Parameter Interpretation (EPP)


## 1. The Fundamental Tension in Prediction Modelling


Every prediction model asks data to reveal patterns. But data always has finite information content: it can reliably teach a limited number of "lessons" before the model begins fitting noise rather than signal.





~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚   <strong>MORE FEATURES </strong> â”€â”€â”€â”€â”€â”€â”€â–º  More potential patterns to discover          â”‚
â”‚        â”‚                                                                â”‚
â”‚        â”‚                   <strong>BUT ALSO</strong>                                     â”‚
â”‚        â–¼                                                                â”‚
â”‚   <strong>MORE PARAMETERS </strong>â”€â”€â”€â”€â”€â”€â–º  More &quot;lessons&quot; the data must teach           â”‚
â”‚        â”‚                                                                â”‚
â”‚        â”‚                   <strong>WHICH MEANS</strong>                                  â”‚
â”‚        â–¼                                                                â”‚
â”‚   <strong>HIGHER RISK</strong> â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â–º  Learning noise instead of signal             â”‚
â”‚                            (overfitting)                                â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚   \textbf{MORE FEATURES } â”€â”€â”€â”€â”€â”€â”€â–º  More potential patterns to discover          â”‚
â”‚        â”‚                                                                â”‚
â”‚        â”‚                   \textbf{BUT ALSO}                                     â”‚
â”‚        â–¼                                                                â”‚
â”‚   \textbf{MORE PARAMETERS }â”€â”€â”€â”€â”€â”€â–º  More "lessons" the data must teach           â”‚
â”‚        â”‚                                                                â”‚
â”‚        â”‚                   \textbf{WHICH MEANS}                                  â”‚
â”‚        â–¼                                                                â”‚
â”‚   \textbf{HIGHER RISK} â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â–º  Learning noise instead of signal             â”‚
â”‚                            (overfitting)                                â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
\end{Verbatim}
~~~




The methodological literature frames this as a sample size problem: 


- _how much data do we need for a given model complexity?_

But the question can be inverted, given the data available: 


- _how much model complexity could researchers support_
- _how much are they researchers actually using_





---


## 2. Why Events Determine Learning Capacity (Not Total N)


For binary outcomes, the effective sample size is determined by the number of outcome events, the less frequent category, not total participants.



### 2.1 Intuition


Consider learning to distinguish people who develop a rare disease:





~~~{=html}
<pre class="notion-ascii-diagram"><code><strong>Scenario A: Common outcome (50% prevalence, 50% have the disease)</strong>
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹ â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹                       â”‚
â”‚  â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹ â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹                       â”‚
â”‚                                                                â”‚
â”‚  N = 40    Events (â—) = 20    Non-events (â—‹) = 20              â”‚
â”‚                                                                â”‚
â”‚  <strong>Abundant examples in both groups</strong>                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

<strong>Scenario B: Rare outcome (5% prevalence, 5% have the disease)</strong>
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹                   â”‚
â”‚  â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â— â— â—‹ â—‹                   â”‚
â”‚                                                            â”‚
â”‚  N = 40    Events (â—) = 2     Non-events (â—‹) = 38          â”‚
â”‚                                                            â”‚
â”‚  <strong>Only 2 examples of the outcome to learn from </strong>             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
\textbf{Scenario A: Common outcome (50% prevalence, 50% have the disease)}
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹ â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹                       â”‚
â”‚  â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹ â— â— â— â— â— â—‹ â—‹ â—‹ â—‹ â—‹                       â”‚
â”‚                                                                â”‚
â”‚  N = 40    Events (â—) = 20    Non-events (â—‹) = 20              â”‚
â”‚                                                                â”‚
â”‚  \textbf{Abundant examples in both groups}                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

\textbf{Scenario B: Rare outcome (5% prevalence, 5% have the disease)}
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹                   â”‚
â”‚  â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â—‹ â— â— â—‹ â—‹                   â”‚
â”‚                                                            â”‚
â”‚  N = 40    Events (â—) = 2     Non-events (â—‹) = 38          â”‚
â”‚                                                            â”‚
â”‚  \textbf{Only 2 examples of the outcome to learn from }             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
\end{Verbatim}
~~~




In Scenario B, despite N=40, the learning capacity is constrained by only 2 events. With only 2 events to learn from, the model cannot reliably estimate many parameters



âˆ´ lower prevalence, have the disease, directly limits how many features can be safely included.



### 2.2 Mathematical Basis


Riley et al. (2019, 2020) formalise this: the number of events bounds the number of parameters that can be estimated with acceptable shrinkage (i.e., without coefficients being systematically too extreme).







---


## 3. The Feature-Parameter Distinction


A critical point often elided in UK Biobank papers: the cost to a model is measured in parameters, not features. The mapping is not 1:1.



### 3.1 Parameter Expansion Rules




~~~{=html}
<pre class="notion-ascii-diagram"><code>FEATURE TYPE                          PARAMETERS REQUIRED
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

Binary (Yes/No)                       1 parameter
   e.g., Sex                          â†’ 1 coefficient

Continuous (linear)                   1 parameter
   e.g., Age in years                 â†’ 1 coefficient

Continuous (non-linear, spline)       3â€“5 parameters typically
   e.g., Age with RCS, 4 knots        â†’ 4 coefficients

Categorical (k levels)                (k âˆ’ 1) parameters
   e.g., Smoking: Never/Former/       â†’ 3 coefficients
         Light/Heavy (4 levels)

Interactions                          Multiplicative
   e.g., Age Ã— Sex                    â†’ 1 additional parameter
   e.g., Age (spline) Ã— Sex           â†’ 4 additional parameters

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
FEATURE TYPE                          PARAMETERS REQUIRED
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

Binary (Yes/No)                       1 parameter
   e.g., Sex                          â†’ 1 coefficient

Continuous (linear)                   1 parameter
   e.g., Age in years                 â†’ 1 coefficient

Continuous (non-linear, spline)       3â€“5 parameters typically
   e.g., Age with RCS, 4 knots        â†’ 4 coefficients

Categorical (k levels)                (k âˆ’ 1) parameters
   e.g., Smoking: Never/Former/       â†’ 3 coefficients
         Light/Heavy (4 levels)

Interactions                          Multiplicative
   e.g., Age Ã— Sex                    â†’ 1 additional parameter
   e.g., Age (spline) Ã— Sex           â†’ 4 additional parameters

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

\end{Verbatim}
~~~




### 3.2 Worked Example: A "6-Feature" Model


Consider a typical UK Biobank core predictor set:





~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  FEATURE-TO-PARAMETER EXPANSION                                     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                     â”‚
â”‚  Feature              Modelling choice         Parameters           â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                     â”‚
â”‚  SIMPLE SPECIFICATION:                                              â”‚
â”‚  Age (21022)          Linear                   1                    â”‚
â”‚  Sex (31)             Binary                   1                    â”‚
â”‚  BMI (21001)          Linear                   1                    â”‚
â”‚  Smoking (20116)      4 categories             3                    â”‚
â”‚  HbA1c (30750)        Linear                   1                    â”‚
â”‚  Townsend (189)       Linear                   1                    â”‚
â”‚                                                â”€â”€â”€â”€â”€                â”‚
â”‚                       Subtotal:                8 parameters         â”‚
â”‚                                                                     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                     â”‚
â”‚  REALISTIC SPECIFICATION (with non-linear terms):                   â”‚
â”‚  Age (21022)          RCS, 4 df                4                    â”‚
â”‚  Sex (31)             Binary                   1                    â”‚
â”‚  BMI (21001)          RCS, 4 df                4                    â”‚
â”‚  Smoking (20116)      4 categories             3                    â”‚
â”‚  HbA1c (30750)        RCS, 4 df                4                    â”‚
â”‚  Townsend (189)       Linear                   1                    â”‚
â”‚                                                â”€â”€â”€â”€â”€                â”‚
â”‚                       Subtotal:                17 parameters        â”‚
â”‚                                                                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

Observation: &quot;6 features&quot; translates to 8â€“17 parameters depending
             on modelling decisions. Papers rarely report this.
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  FEATURE-TO-PARAMETER EXPANSION                                     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                     â”‚
â”‚  Feature              Modelling choice         Parameters           â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                     â”‚
â”‚  SIMPLE SPECIFICATION:                                              â”‚
â”‚  Age (21022)          Linear                   1                    â”‚
â”‚  Sex (31)             Binary                   1                    â”‚
â”‚  BMI (21001)          Linear                   1                    â”‚
â”‚  Smoking (20116)      4 categories             3                    â”‚
â”‚  HbA1c (30750)        Linear                   1                    â”‚
â”‚  Townsend (189)       Linear                   1                    â”‚
â”‚                                                â”€â”€â”€â”€â”€                â”‚
â”‚                       Subtotal:                8 parameters         â”‚
â”‚                                                                     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                     â”‚
â”‚  REALISTIC SPECIFICATION (with non-linear terms):                   â”‚
â”‚  Age (21022)          RCS, 4 df                4                    â”‚
â”‚  Sex (31)             Binary                   1                    â”‚
â”‚  BMI (21001)          RCS, 4 df                4                    â”‚
â”‚  Smoking (20116)      4 categories             3                    â”‚
â”‚  HbA1c (30750)        RCS, 4 df                4                    â”‚
â”‚  Townsend (189)       Linear                   1                    â”‚
â”‚                                                â”€â”€â”€â”€â”€                â”‚
â”‚                       Subtotal:                17 parameters        â”‚
â”‚                                                                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

Observation: "6 features" translates to 8â€“17 parameters depending
             on modelling decisions. Papers rarely report this.

\end{Verbatim}
~~~




---


## 4. Defining Events Per Parameter (EPP)


### 4.1 The Core Ratio




~~~{=html}
<pre class="notion-ascii-diagram"><code>                         Number of outcome events
           EPP    =     â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
                         Number of parameters
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
                         Number of outcome events
           EPP    =     â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
                         Number of parameters

\end{Verbatim}
~~~




### 4.2 Historical Thresholds and Their Limitations


The "10 EPV" rule (events per variable) emerged from 1990s simulation studies (Peduzzi et al., 1996). It was never intended as a universal standard.





~~~{=html}
<pre class="notion-ascii-diagram"><code>EPP INTERPRETATION (approximate, context-dependent)
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

EPP &lt; 10        High overfitting risk
                Coefficient estimates unstable
                Performance degrades on new data
                âš ï¸  Many published models operate here

EPP 10â€“20       Traditional threshold
                van Smeden et al. (2016): not reliable as
                universal criterion

EPP 20â€“50       Generally adequate for logistic regression
                Riley et al. (2019): target shrinkage â‰¥ 0.9

EPP &gt; 50        Comfortable margin
                Still depends on signal strength (RÂ²) and prevalence

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Key point: EPP is necessary but not sufficient. The appropriate
           threshold depends on outcome prevalence, expected RÂ²,
           and tolerable shrinkage.
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
EPP INTERPRETATION (approximate, context-dependent)
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

EPP < 10        High overfitting risk
                Coefficient estimates unstable
                Performance degrades on new data
                âš ï¸  Many published models operate here

EPP 10â€“20       Traditional threshold
                van Smeden et al. (2016): not reliable as
                universal criterion

EPP 20â€“50       Generally adequate for logistic regression
                Riley et al. (2019): target shrinkage â‰¥ 0.9

EPP > 50        Comfortable margin
                Still depends on signal strength (RÂ²) and prevalence

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Key point: EPP is necessary but not sufficient. The appropriate
           threshold depends on outcome prevalence, expected RÂ²,
           and tolerable shrinkage.

\end{Verbatim}
~~~




### 4.3 The Riley et al. (2020) Refinement


Modern sample size calculations incorporate:


1. **Outcome prevalence** â€” determines maximum achievable RÂ²
2. **Anticipated model performance (RÂ²)** â€” weaker signals require more events
3. **Target shrinkage factor** â€” typically â‰¥ 0.9 (â‰¤10% overfitting)
4. **Precision requirements** â€” desired confidence interval width

This yields context-specific sample size requirements rather than fixed EPP thresholds.



---


## 5. UK Biobank: Applying the Framework


### 5.1 Baseline Numbers




~~~{=html}
<pre class="notion-ascii-diagram"><code>UK BIOBANK SCALE
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Total participants:          ~500,000
Available fields/features:   ~10,000+ (direct measures, derived, etc.)

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
UK BIOBANK SCALE
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Total participants:          ~500,000
Available fields/features:   ~10,000+ (direct measures, derived, etc.)

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




### 5.2 EPP-Supportable Complexity by Prevalence




~~~{=html}
<pre class="notion-ascii-diagram"><code>MAXIMUM DEFENSIBLE PARAMETERS AT DIFFERENT PREVALENCES
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

                                           Max parameters at:
Prevalence    Events (N=500k)       EPP=20         EPP=50
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
10.0%         50,000                2,500          1,000
5.0%          25,000                1,250          500
1.0%          5,000                 250            100
0.5%          2,500                 125            50
0.1%          500                   25             10
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

These are UPPER BOUNDS on model complexity given statistical constraints

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
MAXIMUM DEFENSIBLE PARAMETERS AT DIFFERENT PREVALENCES
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

                                           Max parameters at:
Prevalence    Events (N=500k)       EPP=20         EPP=50
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
10.0%         50,000                2,500          1,000
5.0%          25,000                1,250          500
1.0%          5,000                 250            100
0.5%          2,500                 125            50
0.1%          500                   25             10
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

These are UPPER BOUNDS on model complexity given statistical constraints

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




### 5.3 Visual Representation




~~~{=html}
<pre class="notion-ascii-diagram"><code>              PARAMETER BUDGET BY OUTCOME PREVALENCE
              (UK Biobank, N â‰ˆ 500,000, EPP = 20)

Parameters
    â”‚
2500â”¤ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â† 10% prevalence
    â”‚                                                  (50,000 events)
2000â”¤
    â”‚
1500â”¤
    â”‚
1250â”¤ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ              â† 5% prevalence
    â”‚                                                  (25,000 events)
1000â”¤
    â”‚
 750â”¤
    â”‚
 500â”¤
    â”‚
 250â”¤ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ                                        â† 1% prevalence
    â”‚                                                  (5,000 events)
 125â”¤ â–ˆâ–ˆâ–ˆâ–ˆ                                           â† 0.5% prevalence
    â”‚
  25â”¤ â–ˆ                                              â† 0.1% prevalence
    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
              PARAMETER BUDGET BY OUTCOME PREVALENCE
              (UK Biobank, N â‰ˆ 500,000, EPP = 20)

Parameters
    â”‚
2500â”¤ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  â† 10% prevalence
    â”‚                                                  (50,000 events)
2000â”¤
    â”‚
1500â”¤
    â”‚
1250â”¤ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ              â† 5% prevalence
    â”‚                                                  (25,000 events)
1000â”¤
    â”‚
 750â”¤
    â”‚
 500â”¤
    â”‚
 250â”¤ â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ                                        â† 1% prevalence
    â”‚                                                  (5,000 events)
 125â”¤ â–ˆâ–ˆâ–ˆâ–ˆ                                           â† 0.5% prevalence
    â”‚
  25â”¤ â–ˆ                                              â† 0.1% prevalence
    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

\end{Verbatim}
~~~




---


## 6. Inverting the Question: EPP as Diagnostic Tool


### 6.1 The Standard Framing


EPP is conventionally presented as a constraint:


> "Do I have enough events for the features I want to include?"

This protects individual studies from overfitting.



### 6.2 The Investigative Framing


But EPP can equally serve as a diagnostic:


> "Given the events available, why are researchers using so few features?"

This characterises field-wide patterns of feature selection.



### 6.3 The Utilisation Ratio


If we can measure both quantities, we can compute:





~~~{=html}
<pre class="notion-ascii-diagram"><code>                          Parameters actually used
  Utilisation ratio  =   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
                          Parameters supportable (EPP)
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
                          Parameters actually used
  Utilisation ratio  =   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
                          Parameters supportable (EPP)

\end{Verbatim}
~~~




---


## 7. Hypothetical Scenarios


### 7.1 Utilisation Near Capacity




~~~{=html}
<pre class="notion-ascii-diagram"><code>SCENARIO A: Researchers approaching statistical limits
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Study parameters:
  - Outcome prevalence: 5%
  - Events: 25,000
  - EPP threshold: 20
  - Supportable parameters: 1,250

Observed:
  - Parameters used: 1,100 (â‰ˆ 200+ features with expansions)

Utilisation ratio: 1,100 / 1,250 = 88%

Interpretation:
  Feature selection appears constrained by EPP.
  Researchers are exploring near the statistical limit.
  Underutilisation is NOT occurring.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
SCENARIO A: Researchers approaching statistical limits
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Study parameters:
  - Outcome prevalence: 5%
  - Events: 25,000
  - EPP threshold: 20
  - Supportable parameters: 1,250

Observed:
  - Parameters used: 1,100 (â‰ˆ 200+ features with expansions)

Utilisation ratio: 1,100 / 1,250 = 88%

Interpretation:
  Feature selection appears constrained by EPP.
  Researchers are exploring near the statistical limit.
  Underutilisation is NOT occurring.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




### 7.2 Utilisation Far Below Capacity




~~~{=html}
<pre class="notion-ascii-diagram"><code>SCENARIO B: Researchers far below statistical limits
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Study parameters:
  - Outcome prevalence: 5%
  - Events: 25,000
  - EPP threshold: 20
  - Supportable parameters: 1,250

Observed:
  - Parameters used: 50 (â‰ˆ 20â€“30 features)

Utilisation ratio: 50 / 1,250 = 4%

Interpretation:
  Researchers are using only 4% of their statistical budget.
  The constraint is NOT EPP.
  Something else is limiting feature exploration.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
SCENARIO B: Researchers far below statistical limits
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Study parameters:
  - Outcome prevalence: 5%
  - Events: 25,000
  - EPP threshold: 20
  - Supportable parameters: 1,250

Observed:
  - Parameters used: 50 (â‰ˆ 20â€“30 features)

Utilisation ratio: 50 / 1,250 = 4%

Interpretation:
  Researchers are using only 4% of their statistical budget.
  The constraint is NOT EPP.
  Something else is limiting feature exploration.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




---


## 8. What Low Utilisation Could Indicate


If systematic analysis reveals UK Biobank studies consistently operate far below EPP capacity, several hypotheses emerge:



### 8.1 Hypothesis: Convergence on a "Core" Feature Set




~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚   10,000+ available UK Biobank features                                 â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                         â–²                                               â”‚
â”‚                         â”‚                                               â”‚
â”‚                &quot;Core&quot; ~50 features?                                     â”‚
â”‚                (heavily reused across studies)                          â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

If this pattern exists empirically, possible explanations include:

  â€¢ These features are genuinely most predictive for most outcomes
  â€¢ These features are most accessible (complete, easy to process)
  â€¢ Citation/replication practices reinforce &quot;established&quot; predictors
  â€¢ Methods sections are copied from prior work
  â€¢ Reviewers expect to see familiar features
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚   10,000+ available UK Biobank features                                 â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–“â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â”‚ â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘â–‘ â”‚â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜â”‚
â”‚                         â–²                                               â”‚
â”‚                         â”‚                                               â”‚
â”‚                "Core" ~50 features?                                     â”‚
â”‚                (heavily reused across studies)                          â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

If this pattern exists empirically, possible explanations include:

  â€¢ These features are genuinely most predictive for most outcomes
  â€¢ These features are most accessible (complete, easy to process)
  â€¢ Citation/replication practices reinforce "established" predictors
  â€¢ Methods sections are copied from prior work
  â€¢ Reviewers expect to see familiar features

\end{Verbatim}
~~~




### 8.2 Hypothesis: Outcome-Feature Mismatch




~~~{=html}
<pre class="notion-ascii-diagram"><code>EXPECTED PATTERN (if feature selection is outcome-driven):
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Different outcomes should draw on different feature pools

Cardiovascular outcomes:              Neurological outcomes:
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”          â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Lipids                  â”‚          â”‚ Cognitive tests         â”‚
â”‚ Blood pressure          â”‚          â”‚ Brain imaging           â”‚
â”‚ ECG measures            â”‚          â”‚ Reaction time           â”‚
â”‚ Exercise capacity       â”‚          â”‚ Mood/sleep              â”‚
â”‚ Smoking, diet           â”‚          â”‚ Education               â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜          â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
        Distinct feature pools with limited overlap


ALTERNATIVE PATTERN (if a core exists):
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Different outcomes draw on same feature pool

Cardiovascular outcomes:              Neurological outcomes:
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”          â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Age, Sex, BMI           â”‚          â”‚ Age, Sex, BMI           â”‚
â”‚ Smoking status          â”‚          â”‚ Smoking status          â”‚
â”‚ Townsend index          â”‚          â”‚ Townsend index          â”‚
â”‚ Blood pressure          â”‚          â”‚ Blood pressure          â”‚
â”‚ ...                     â”‚          â”‚ ...                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜          â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
        Near-identical despite distinct clinical domains

If so: Are outcome-specific features being systematically ignored?

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
EXPECTED PATTERN (if feature selection is outcome-driven):
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Different outcomes should draw on different feature pools

Cardiovascular outcomes:              Neurological outcomes:
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”          â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Lipids                  â”‚          â”‚ Cognitive tests         â”‚
â”‚ Blood pressure          â”‚          â”‚ Brain imaging           â”‚
â”‚ ECG measures            â”‚          â”‚ Reaction time           â”‚
â”‚ Exercise capacity       â”‚          â”‚ Mood/sleep              â”‚
â”‚ Smoking, diet           â”‚          â”‚ Education               â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜          â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
        Distinct feature pools with limited overlap


ALTERNATIVE PATTERN (if a core exists):
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Different outcomes draw on same feature pool

Cardiovascular outcomes:              Neurological outcomes:
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”          â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Age, Sex, BMI           â”‚          â”‚ Age, Sex, BMI           â”‚
â”‚ Smoking status          â”‚          â”‚ Smoking status          â”‚
â”‚ Townsend index          â”‚          â”‚ Townsend index          â”‚
â”‚ Blood pressure          â”‚          â”‚ Blood pressure          â”‚
â”‚ ...                     â”‚          â”‚ ...                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜          â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
        Near-identical despite distinct clinical domains

If so: Are outcome-specific features being systematically ignored?

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




### 8.3 Hypothesis: Wrong Features, Not Just Few Features


EPP constrains how many parameters can be estimated. It says nothing about whether the right parameters are being estimated.





~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  Two models, both statistically adequate (EPP = 50)                     â”‚
â”‚                                                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚ MODEL A: Features with genuine predictive/causal relationships  â”‚   â”‚
â”‚  â”‚                                                                 â”‚   â”‚
â”‚  â”‚   â†’ Good discrimination (AUC ~ 0.80)                            â”‚   â”‚
â”‚  â”‚   â†’ Stable calibration across populations                       â”‚   â”‚
â”‚  â”‚   â†’ Transportable to external cohorts                           â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚ MODEL B: Features that are proxies, confounded, or local        â”‚   â”‚
â”‚  â”‚                                                                 â”‚   â”‚
â”‚  â”‚   â†’ Modest discrimination (AUC ~ 0.65)                          â”‚   â”‚
â”‚  â”‚   â†’ Calibration degrades on external validation                 â”‚   â”‚
â”‚  â”‚   â†’ Poor transportability                                       â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                                         â”‚
â”‚  EPP CANNOT DISTINGUISH BETWEEN A AND B                                 â”‚
â”‚                                                                         â”‚
â”‚  If researchers consistently select from a narrow pool, they may:       â”‚
â”‚    â€¢ Miss features that would improve prediction                        â”‚
â”‚    â€¢ Include features by convention rather than evidence                â”‚
â”‚    â€¢ Fail to consider disease-specific biology                          â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  Two models, both statistically adequate (EPP = 50)                     â”‚
â”‚                                                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚ MODEL A: Features with genuine predictive/causal relationships  â”‚   â”‚
â”‚  â”‚                                                                 â”‚   â”‚
â”‚  â”‚   â†’ Good discrimination (AUC ~ 0.80)                            â”‚   â”‚
â”‚  â”‚   â†’ Stable calibration across populations                       â”‚   â”‚
â”‚  â”‚   â†’ Transportable to external cohorts                           â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                                         â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚ MODEL B: Features that are proxies, confounded, or local        â”‚   â”‚
â”‚  â”‚                                                                 â”‚   â”‚
â”‚  â”‚   â†’ Modest discrimination (AUC ~ 0.65)                          â”‚   â”‚
â”‚  â”‚   â†’ Calibration degrades on external validation                 â”‚   â”‚
â”‚  â”‚   â†’ Poor transportability                                       â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                                         â”‚
â”‚  EPP CANNOT DISTINGUISH BETWEEN A AND B                                 â”‚
â”‚                                                                         â”‚
â”‚  If researchers consistently select from a narrow pool, they may:       â”‚
â”‚    â€¢ Miss features that would improve prediction                        â”‚
â”‚    â€¢ Include features by convention rather than evidence                â”‚
â”‚    â€¢ Fail to consider disease-specific biology                          â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

\end{Verbatim}
~~~




---


## 9. Medical Ontologies as Independent Benchmark


Medical ontologies (MONDO, HPO, EFO, ICD-10, SNOMED-CT) encode structured domain knowledge:


- Which biological processes relate to which diseases
- Which measurements reflect which physiological states
- Which features _should_ be relevant based on clinical/biological reasoning

This provides an independent reference point, separate from what papers actually use.



### 9.1 Example: Type 2 Diabetes




~~~{=html}
<pre class="notion-ascii-diagram"><code>ONTOLOGY-DERIVED EXPECTED FEATURES FOR T2D (MONDO:0005148)
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Domain knowledge suggests these feature categories are relevant:

â”œâ”€â”€ Metabolic markers
â”‚   â”œâ”€â”€ HbA1c
â”‚   â”œâ”€â”€ Fasting glucose
â”‚   â”œâ”€â”€ Insulin levels
â”‚   â”œâ”€â”€ C-peptide
â”‚   â””â”€â”€ Lipid panel (TG, HDL, LDL)
â”‚
â”œâ”€â”€ Anthropometric
â”‚   â”œâ”€â”€ BMI
â”‚   â”œâ”€â”€ Waist circumference
â”‚   â”œâ”€â”€ Waist-hip ratio
â”‚   â””â”€â”€ Body fat percentage
â”‚
â”œâ”€â”€ Genetic/familial
â”‚   â”œâ”€â”€ TCF7L2 variants
â”‚   â”œâ”€â”€ Polygenic risk scores
â”‚   â””â”€â”€ Family history
â”‚
â”œâ”€â”€ Lifestyle
â”‚   â”œâ”€â”€ Physical activity measures
â”‚   â”œâ”€â”€ Diet composition
â”‚   â”œâ”€â”€ Sleep duration/quality
â”‚   â””â”€â”€ Alcohol consumption
â”‚
â”œâ”€â”€ Comorbidity indicators
â”‚   â”œâ”€â”€ Blood pressure
â”‚   â”œâ”€â”€ Kidney function (eGFR, creatinine)
â”‚   â”œâ”€â”€ Liver function (ALT, GGT)
â”‚   â””â”€â”€ Inflammatory markers (CRP)
â”‚
â””â”€â”€ Sociodemographic
    â”œâ”€â”€ Age
    â”œâ”€â”€ Sex
    â”œâ”€â”€ Ethnicity
    â””â”€â”€ Deprivation indices

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Empirical question: What features do T2D prediction papers actually use?

Gap between ontology-suggested and actually-used = potential underutilisation

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
ONTOLOGY-DERIVED EXPECTED FEATURES FOR T2D (MONDO:0005148)
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Domain knowledge suggests these feature categories are relevant:

â”œâ”€â”€ Metabolic markers
â”‚   â”œâ”€â”€ HbA1c
â”‚   â”œâ”€â”€ Fasting glucose
â”‚   â”œâ”€â”€ Insulin levels
â”‚   â”œâ”€â”€ C-peptide
â”‚   â””â”€â”€ Lipid panel (TG, HDL, LDL)
â”‚
â”œâ”€â”€ Anthropometric
â”‚   â”œâ”€â”€ BMI
â”‚   â”œâ”€â”€ Waist circumference
â”‚   â”œâ”€â”€ Waist-hip ratio
â”‚   â””â”€â”€ Body fat percentage
â”‚
â”œâ”€â”€ Genetic/familial
â”‚   â”œâ”€â”€ TCF7L2 variants
â”‚   â”œâ”€â”€ Polygenic risk scores
â”‚   â””â”€â”€ Family history
â”‚
â”œâ”€â”€ Lifestyle
â”‚   â”œâ”€â”€ Physical activity measures
â”‚   â”œâ”€â”€ Diet composition
â”‚   â”œâ”€â”€ Sleep duration/quality
â”‚   â””â”€â”€ Alcohol consumption
â”‚
â”œâ”€â”€ Comorbidity indicators
â”‚   â”œâ”€â”€ Blood pressure
â”‚   â”œâ”€â”€ Kidney function (eGFR, creatinine)
â”‚   â”œâ”€â”€ Liver function (ALT, GGT)
â”‚   â””â”€â”€ Inflammatory markers (CRP)
â”‚
â””â”€â”€ Sociodemographic
    â”œâ”€â”€ Age
    â”œâ”€â”€ Sex
    â”œâ”€â”€ Ethnicity
    â””â”€â”€ Deprivation indices

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

Empirical question: What features do T2D prediction papers actually use?

Gap between ontology-suggested and actually-used = potential underutilisation

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




---


## 10. A Testable Research Framework


The EPP framework enables a specific, quantitative research programme:



### 10.1 Three Quantities to Compare




~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  For each UK Biobank prediction study, measure:                         â”‚
â”‚                                                                         â”‚
â”‚    (a) STATISTICAL CAPACITY                                             â”‚
â”‚        Parameters supportable given event count and EPP threshold       â”‚
â”‚        â†’ Calculated from: events / EPP_threshold                        â”‚
â”‚                                                                         â”‚
â”‚    (b) ACTUAL UTILISATION                                               â”‚
â”‚        Parameters actually used in the published model                  â”‚
â”‚        â†’ Extracted from: methods sections, supplementary materials      â”‚
â”‚                                                                         â”‚
â”‚    (c) DOMAIN EXPECTATION                                               â”‚
â”‚        Features suggested by medical ontologies for that outcome        â”‚
â”‚        â†’ Derived from: MONDO, HPO, EFO mappings to UKB fields           â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  For each UK Biobank prediction study, measure:                         â”‚
â”‚                                                                         â”‚
â”‚    (a) STATISTICAL CAPACITY                                             â”‚
â”‚        Parameters supportable given event count and EPP threshold       â”‚
â”‚        â†’ Calculated from: events / EPP_threshold                        â”‚
â”‚                                                                         â”‚
â”‚    (b) ACTUAL UTILISATION                                               â”‚
â”‚        Parameters actually used in the published model                  â”‚
â”‚        â†’ Extracted from: methods sections, supplementary materials      â”‚
â”‚                                                                         â”‚
â”‚    (c) DOMAIN EXPECTATION                                               â”‚
â”‚        Features suggested by medical ontologies for that outcome        â”‚
â”‚        â†’ Derived from: MONDO, HPO, EFO mappings to UKB fields           â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

\end{Verbatim}
~~~




### 10.2 Visual Comparison




~~~{=html}
<pre class="notion-ascii-diagram"><code>         â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
         â”‚                                                      â”‚
         â”‚    (a)              (c)              (b)              â”‚
         â”‚   â”Œâ”€â”€â”€â”           â”Œâ”€â”€â”€â”            â”Œâ”€â”€â”€â”             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â””â”€â”€â”€â”˜           â””â”€â”€â”€â”˜            â””â”€â”€â”€â”˜             â”‚
         â”‚  Statistical      Ontology-        Actually          â”‚
         â”‚  capacity         suggested        used              â”‚
         â”‚                                                      â”‚
         â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
         â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
         â”‚                                                      â”‚
         â”‚    (a)              (c)              (b)              â”‚
         â”‚   â”Œâ”€â”€â”€â”           â”Œâ”€â”€â”€â”            â”Œâ”€â”€â”€â”             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â”‚   â”‚           â”‚   â”‚            â”‚   â”‚             â”‚
         â”‚   â””â”€â”€â”€â”˜           â””â”€â”€â”€â”˜            â””â”€â”€â”€â”˜             â”‚
         â”‚  Statistical      Ontology-        Actually          â”‚
         â”‚  capacity         suggested        used              â”‚
         â”‚                                                      â”‚
         â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

\end{Verbatim}
~~~




### 10.3 Interpretation Matrix




~~~{=html}
<pre class="notion-ascii-diagram"><code>PATTERN                              INTERPRETATION
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

(b) â‰ˆ (a)                            Researchers operating at statistical
                                     limits. No evidence of underutilisation.

(b) &lt;&lt; (a) and (b) &lt;&lt; (c)            Systematic underutilisation.
                                     Statistical capacity is unused.
                                     Domain-relevant features ignored.
                                     â†’ STRONGEST EVIDENCE FOR PROBLEM

(b) &lt;&lt; (a) but (b) â‰ˆ (c)             Conservative but domain-appropriate.
                                     Using fewer features than possible,
                                     but aligned with domain knowledge.

(b) â‰ˆ (a) but (b) â‰  (c)              EPP-constrained but potentially
                                     mis-specified. Operating at limits
                                     but feature choice may not match
                                     domain expectations.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
PATTERN                              INTERPRETATION
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

(b) â‰ˆ (a)                            Researchers operating at statistical
                                     limits. No evidence of underutilisation.

(b) << (a) and (b) << (c)            Systematic underutilisation.
                                     Statistical capacity is unused.
                                     Domain-relevant features ignored.
                                     â†’ STRONGEST EVIDENCE FOR PROBLEM

(b) << (a) but (b) â‰ˆ (c)             Conservative but domain-appropriate.
                                     Using fewer features than possible,
                                     but aligned with domain knowledge.

(b) â‰ˆ (a) but (b) â‰  (c)              EPP-constrained but potentially
                                     mis-specified. Operating at limits
                                     but feature choice may not match
                                     domain expectations.

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




---


## 11. Methodological Implications


### 11.1 What Finding a "Core" Would Mean


If analysis reveals:


- A small set of features (~50) accounts for majority of feature usage
- This set is stable across diverse outcomes (cardiovascular, neurological, etc.)
- Studies operate far below EPP capacity

Then we have quantitative evidence for systematic underutilisation â€” potentially a self-reinforcing pattern where researchers use familiar features regardless of outcome-specific relevance.



### 11.2 What This Does NOT Prove


Important limitations:





~~~{=html}
<pre class="notion-ascii-diagram"><code>â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  EPP analysis can show:                                                 â”‚
â”‚    âœ“ Gap between capacity and utilisation                               â”‚
â”‚    âœ“ Whether feature usage varies by outcome                            â”‚
â”‚    âœ“ Degree of convergence on common features                           â”‚
â”‚                                                                         â”‚
â”‚  EPP analysis cannot show:                                              â”‚
â”‚    âœ— That unused features would improve prediction                      â”‚
â”‚    âœ— That commonly used features are wrong                              â”‚
â”‚    âœ— Causal relationships between features and outcomes                 â”‚
â”‚                                                                         â”‚
â”‚  The framework is DIAGNOSTIC, not PRESCRIPTIVE                          â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                         â”‚
â”‚  EPP analysis can show:                                                 â”‚
â”‚    âœ“ Gap between capacity and utilisation                               â”‚
â”‚    âœ“ Whether feature usage varies by outcome                            â”‚
â”‚    âœ“ Degree of convergence on common features                           â”‚
â”‚                                                                         â”‚
â”‚  EPP analysis cannot show:                                              â”‚
â”‚    âœ— That unused features would improve prediction                      â”‚
â”‚    âœ— That commonly used features are wrong                              â”‚
â”‚    âœ— Causal relationships between features and outcomes                 â”‚
â”‚                                                                         â”‚
â”‚  The framework is DIAGNOSTIC, not PRESCRIPTIVE                          â”‚
â”‚                                                                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

\end{Verbatim}
~~~




---


## 12. Summary: EPP as Investigative Tool




~~~{=html}
<pre class="notion-ascii-diagram"><code>â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

TRADITIONAL VIEW                      INVESTIGATIVE VIEW
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

&quot;Do I have enough events              &quot;Given available events, why are
 for my features?&quot;                     researchers using so few features?&quot;

EPP as constraint                      EPP as counterfactual

Protects individual studies            Characterises field-wide patterns
from overfitting                       of feature selection

Answers: &quot;Is this study               Answers: &quot;Is the field exploring
         adequately powered?&quot;                   available data?&quot;

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

The question is not just whether UK Biobank studies meet EPP thresholds.

The more interesting question:

  WHY DO THEY OPERATE SO FAR BELOW THEM,
  AND WHAT ARE WE POTENTIALLY MISSING AS A RESULT?

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
</code></pre>
~~~

~~~{=latex}
\begin{Verbatim}[commandchars=\\\{\}]
â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

TRADITIONAL VIEW                      INVESTIGATIVE VIEW
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

"Do I have enough events              "Given available events, why are
 for my features?"                     researchers using so few features?"

EPP as constraint                      EPP as counterfactual

Protects individual studies            Characterises field-wide patterns
from overfitting                       of feature selection

Answers: "Is this study               Answers: "Is the field exploring
         adequately powered?"                   available data?"

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

The question is not just whether UK Biobank studies meet EPP thresholds.

The more interesting question:

  WHY DO THEY OPERATE SO FAR BELOW THEM,
  AND WHAT ARE WE POTENTIALLY MISSING AS A RESULT?

â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•

\end{Verbatim}
~~~




---


## References


Collins, G.S., Moons, K.G.M., Dhiman, P., et al. (2024) 'TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods', BMJ, 385:e078378.



Martin, G.P., Riley, R.D., Ensor, J., & Grant, S.W. (2025) 'Statistical primer: sample size considerations for developing and validating clinical prediction models', European Journal of Cardio-Thoracic Surgery, 67(5):ezaf142.



Moons, K.G.M., Damen, J.A.A., Kaul, T., et al. (2025) 'PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods', BMJ, 388:e082505.



Peduzzi, P., Concato, J., Kemper, E., Holford, T.R. & Feinstein, A.R. (1996) 'A simulation study of the number of events per variable in logistic regression analysis', Journal of Clinical Epidemiology, 49(12), pp.1373â€“1379.



Riley, R.D., Snell, K.I.E., Ensor, J., et al. (2019) 'Minimum sample size for developing a multivariable prediction model: Part II â€“ binary and time-to-event outcomes', Statistics in Medicine, 38(7), pp.1276â€“1296.



Riley, R.D., Ensor, J., Snell, K.I.E., et al. (2020) 'Calculating the sample size required for developing a clinical prediction model', BMJ, 368:m441.



van der Ploeg, T., Austin, P.C. & Steyerberg, E.W. (2014) 'Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints', BMC Medical Research Methodology, 14:137.



van Smeden, M., de Groot, J.A.H., Moons, K.G.M., et al. (2016) 'No rationale for 1 variable per 10 events criterion for binary logistic regression analysis', BMC Medical Research Methodology, 16:163.



---


Last updated: January 2026


